呼吸器薬物送達市場レポート：2024-2034

Respiratory Drug Delivery Market Report 2024-2034

レポート詳細呼吸器薬物送達市場レポート 2024-2034年：本レポートは、業界とその基礎となるダイナミクスをより良く理解したい場合、新たな収益ポケットを目指している大手企業にとって貴重なもの... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
Visiongain ヴィジョンゲイン社	2024年1月23日	GBP5,150 部署ライセンスライセンス・価格情報注文方法はこちら	348	396	英語

※上記価格は部署ライセンス（Departmental licence）価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

目次
図表リスト

サマリー

レポート詳細

呼吸器薬物送達市場レポート 2024-2034年：本レポートは、業界とその基礎となるダイナミクスをより良く理解したい場合、新たな収益ポケットを目指している大手企業にとって貴重なものとなるでしょう。異業種への進出や新規地域での既存事業の拡大を目指す企業にも有用です。

スマート／デジタル吸入器の発売とCOVID-19パンデミックの発生が業界の成長を促進すると予測される

現在のところ、スマート吸入器は、使用中の患者の操作（時間と日付のスタンプ）を記録するだけである。数多くの企業が、現在使用中の吸入器に接続できるデバイスを製造している。このトレンドをリードしているのは、ニュージーランドで設立されたアメリカのプロペラ・ヘルス社とアドヘリウム社である。両社が実施した臨床研究のデータから、患者が両社の製品を利用することでメリットを得られる可能性があることが示されている。別の例では、イノベイトUKが2023年1月、慢性呼吸器疾患患者向けのインテリジェント吸入器の開発を専門とするアセプティカ社に共同資金を提供した。5Gモバイル接続を統合した同社の第3世代スマート吸入トラッカーは、Smart Awardの支援を受けてさらに開発される予定だ。

COVID-19は特定の肺組織に影響を及ぼすため、治療の一環として気管支拡張剤が頻繁に使用される。ネブライザーは患者にエアロゾル化したウイルスの生成を促す可能性があり、COVID-19の拡散を悪化させる可能性がある。このため、MDIの使用が推奨される。COVID-19治療に対する医療ニーズは高まっており、吸入器が不足している。例えば、2022年10月にGenScript ProBioとHibiocy Co.Ltd.との間で、COVID-19のヒト抗体を含む呼吸ケア用医療機器COVITRAPの開発を加速するための戦略的契約を2022年10月に締結した。COVID-19ウイルスが鼻腔内表面に付着するのを防ぐことで、点鼻薬であるCOVITRAPは鼻腔内に存在するウイルス量を減少させることができる。タイのFDAによる承認後、COVITRAPは正式にタイ市場で発売された。これは、COVID-19の大流行の反動で、ウイルス患者だけでなく、気管支炎、喘息、その他の呼吸器疾患に苦しむ患者を治療するための呼吸器薬送達技術に対する需要が高まっていることを示している。

厳しい政府規制が業界の成長を阻む可能性が高い
FDAは通常、製品を販売する前に、医療機器、医薬品、医薬品技術を承認するために、長く骨の折れるプロセスを経る。これは通常、新製品を市場に投入するために集中的な研究開発を行う企業にとって難題となる。当局は、一般消費者に販売する前に、製品の安全性と使用方法を厳しく検証する。MDIとDPIは、97品目の医薬品と医療機器の組み合わせとして、医薬品と医療機器に関する現行の適正製造規範（CGMP）要件の対象となる混合製品である。特に、設計管理（21 CFR 820.30）の対象となるデバイスコンポーネントを有する全てのMDIとDPIに適用される。医薬品開発に関する業界ガイドラインは、設計による品質（Quality via Design）の概念に基づき、製品の設計及び開発のプロセスを対象としている。設計による品質と設計管理は同じ特徴及び目的を有するが、医療機器の品質システム規制（21 CFR 820）は設計要件を規定している。

市場調査レポートを購入する前にすべき質問とは？

呼吸器薬物送達市場はどのように進化しているのか？
呼吸器薬物送達市場の推進要因と阻害要因は何か？
ポイントオブケア診断の各サブマーケットは予測期間中にどのように成長し、2034年にはどれくらいの収益を占めるようになるのか？
2024年から2034年にかけて、呼吸器薬物送達の各サブマーケットの市場シェアはどのように推移するのか？
2024年から2034年にかけて、市場全体を牽引する主な要因は何か？
主要な呼吸器薬物送達市場は、マクロ経済のダイナミクスに広く追随するのだろうか、それとも個々の国市場が他を凌駕するのだろうか？
2034年までに各国市場のシェアはどのように変化し、どの地域が2034年の市場をリードするのか。
主要プレーヤーと予測期間中の見通しは？
これらの大手企業による呼吸器薬物送達プロジェクトとは？
2024年から2034年の間に、業界はどのように発展するのか？現在、そして今後10年間に行われる呼吸器薬物送達プロジェクトはどのような意味を持つのか？
呼吸器薬物送達市場をさらに拡大するために、製品化の必要性は高まっているのだろうか？
呼吸器薬物送達市場はどこに向かっているのか、そしてどのようにすれば市場の最前線に立てるのか？
新商品や新サービスに最適な投資方法とは？
企業を新たな成長軌道に乗せ、C-suiteに移行させるための重要な展望とは？

このことが呼吸器薬物送達市場の現在と今後10年間にどのような影響を与えるかを知る必要がある：

348ページに及ぶレポートには、147の表、249のグラフ、そしてグラフが掲載されている。
について本レポートでは、業界の主要な有利分野を取り上げている。今すぐ
世界、地域、国の売上高と成長に関する詳細な分析が含まれている。
競合他社が成功した主なトレンド、変化、収益予測をハイライトします。

本レポートは、呼吸器薬物送達市場が今後10年間にどのように発展するか、またCOVID-19の景気後退と好転の変動に合わせてどのように発展するかをお伝えするものです。この市場は、過去10年間のどの時点よりも今が重要である。

2034年までの予測やその他の分析から、商業的な展望が明らかになる

2034年までの収益予測に加え、最近の実績、成長率、市場シェアも提供している。
ビジネスの展望や展開など、独自の分析が掲載されている。
定性的分析（市場ダイナミクス、促進要因、機会、阻害要因、課題を含む）、呼吸器薬物送達価格上昇の影響、最近の動向をご覧いただけます。

本レポートには、COVID-19が業界と貴社にどのような影響を与えるかについてのデータ分析と貴重な洞察が含まれている。本レポートでは、COVID-19の4つの回収パターンとその影響、すなわち「V」、「L」、「W」、「U」について論じている。

レポート対象セグメント

製品

製剤
デバイス

製剤

乾燥粉末
懸濁液エアゾール
溶液エアゾール

デバイス

定量吸入器（MDI）
ドライパウダー吸入器（DPI）
ネブライザー
アクセサリー

ネブライザー

ソフトミストネブライザー
ジェットネブライザー
超音波ネブライザー

キャニスター

プレーンキャニスター
コーティングキャニスター

用途

喘息
慢性閉塞性肺疾患
嚢胞性線維症
その他

エンドユーザー

在宅介護環境
病院・クリニック
その他のエンドユーザー

世界市場全体と各分野の売上予測に加え、5つの地域と25の主要国市場の売上予測も掲載しています：

北米

米国
カナダ

欧州

ドイツ
英国
フランス
イタリア
スペイン
スイス
ロシア
その他の欧州

アジア太平洋

中国
日本
インド
オーストラリア
韓国
東南アジア
その他のアジア太平洋

ラテンアメリカ

ブラジル
メキシコ
アルゼンチン
その他のラテンアメリカ

MEA

GCC
南アフリカ
エジプト
その他のMEA

また、本レポートには、呼吸器官用薬物送達市場の2024年から2034年までの主要企業のプロファイルと、これらの企業の事業のこのセグメントに焦点を当てている。

報告書に掲載されている主要企業

3M
AptarGroup Inc.
AstraZeneca
Boehringer Ingelheim International GmbH
Cipla Inc.
GF Health Products Inc.
Glenmark Pharmaceuticals Ltd.
GSK plc.
Koninklijke Philips N.V.
Medisana GmbH
Merck & Co.
Novartis AG
Omron Corporation
Recipharm AB
Sumitomo Pharma Co., Ltd.
Teva Pharmaceutical Industries Ltd.
Vapotherm

2024年から2034年までの呼吸器薬物送達市場の世界全体の売上高（金額ベース）は、2024年に670億米ドルを突破する。2034年まで力強い収益成長を予測。当調査では、最も大きな可能性を秘めた企業を特定しています。彼らの能力、進歩、商業的展望を発見し、一歩先を行くお手伝いをします。

呼吸器薬物送達市場、2024-2034年レポートはどのようにお役に立ちますか？

要約すると、340ページを超えるこのレポートは、以下のような知識を提供する：

呼吸器薬物送達市場の2024年から2034年までの収益予測、製品、製剤、デバイス、ネブライザー、キャニスター、用途、エンドユーザーごとの予測を世界レベルと地域レベルで掲載 - 業界の展望を発見し、投資と収益に最も有利な場所を見つけます。
5つの地域と25の主要国市場の2034年までの収益予測 - 呼吸器薬物送達市場の2024年から2034年までの北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、MEAの市場予測をご覧ください。また、米国、カナダ、メキシコ、ブラジル、ドイツ、フランス、英国、イタリア、スペイン、スイス、ロシア、中国、インド、日本、オーストラリア、韓国、東南アジア、アルゼンチン、GCC、南アフリカ、エジプトなどの主要経済圏の市場も予測しています。
既存企業および市場参入を目指す企業の展望 - 呼吸器薬物送達市場に関与する主要企業17社の企業プロファイルを含む、2024年から2034年までの展望。

独自の予測による定量的・定性的分析をご覧ください。私たちのレポートだけに含まれる情報を入手し、貴重なビジネスインテリジェンスで情報を得ることができます。

他にはない情報

私たちの新しいレポートがあれば、知識に遅れをとったり、チャンスを逃したりする可能性が低くなります。弊社の調査レポートが貴社の調査、分析、意思決定にどのように役立つかをご覧ください。Visiongainの調査は、呼吸器薬物送達市場、2024年から2034年、市場をリードする企業の商業分析を必要とするすべての人のためのものです。データ、トレンド、予測をご覧いただけます。

ページTOPに戻る

1 レポート概要
1.1 研究の目的
1.2 呼吸器薬物送達市場の紹介
1.3 本レポートの内容
1.4 本レポートを読むべき理由
1.5 本分析レポートが回答する主な質問
1.6 本レポートは誰のためのものか？
1.7 方法論
1.7.1 市場の定義
1.7.2 市場評価・予測手法
1.7.3 データの検証
1.7.3.1 一次調査
1.7.3.2 セカンダリーリサーチ
1.8 よくある質問（FAQ）
1.9 Visiongainの関連レポート
1.10 Visiongainについて

2 エグゼクティブ・サマリー

3 市場概要
3.1 主要な調査結果
3.2 市場ダイナミクス
3.2.1 市場促進要因
3.2.1.2 呼吸器薬物送達における技術的進歩が市場を押し上げる見込み
3.2.1.3 COVID-19パンデミックの発生
3.2.1.4 呼吸器疾患医療啓発に対する政府およびNGOの支援の高まり
3.2.1.5 スマート／デジタル吸入器の発売は高度な薬物送達デバイスの採用を促進する
3.2.2 市場抑制要因
3.2.2.1 厳しい政府規制が市場成長の妨げになると予想される
3.2.2.2 ベンダー間の激しい競争が市場成長を抑制すると予測される
3.2.2.3 価格圧力が大きな課題
3.2.2.4 呼吸器用薬剤の送達設計に関連する課題
3.2.3 市場機会
3.2.3.1 定量吸入器（MDI）技術の動向は近未来の市場を促進する見込み
3.2.3.2 市場プレイヤーによる合併、契約、買収は市場で目撃された主要な傾向である
3.2.3.3 ドライパウダー薬物送達製品の革新が呼吸器系薬剤の採用を促進
3.2.3.4 肺薬物送達システムの研究開発の増加
3.3 COVID-19の影響分析
3.4 ポーターのファイブフォース分析
3.4.1 サプライヤーの交渉力：高
3.4.2 新規参入の脅威：中
3.4.3 買い手の交渉力：中
3.4.4 競争上のライバル：高
3.4.5 代替品の脅威：中
3.5 SWOT分析
3.6 PEST分析
3.6.1 呼吸器薬物送達市場に影響を与える政治的要因
3.6.2 呼吸器薬物送達市場に影響を与える経済的要因
3.6.3 呼吸器薬物送達市場に影響を与える社会的要因
3.6.4 呼吸器薬物送達市場に影響を与える技術的要因

4 呼吸器薬物送達市場分析：製品別
4.1 主要な調査結果
4.2 製品セグメント市場魅力度指数
4.3 呼吸器官用薬物送達の製品別市場規模の推定と予測
4.4 製剤
4.4.1 2024〜2034年の地域別市場規模（US$ Billion）
4.4.2 地域別市場シェア、2024年・2034年(%)
4.5 デバイス
4.5.1 2024〜2034年地域別市場規模（US$ Billion）
4.5.2 地域別市場シェア、2024年・2034年(%)

5 呼吸器薬物送達市場：製剤別
5.1 主要調査結果
5.2 製剤セグメント市場魅力度指数
5.3 呼吸器薬物送達市場：製剤別
5.4 ドライパウダー製剤
5.4.1 2024〜2034年の地域別市場規模（US$ Billion）
5.4.2 地域別市場シェア、2024年・2034年(%)
5.5 懸濁エアゾール
5.5.1 2024〜2034年の地域別市場規模（US$ Billion）
5.5.2 地域別市場シェア、2024年・2034年(%)
5.6 液剤エアゾール
5.6.1 2024〜2034年の地域別市場規模（US$ Billion）
5.6.2 地域別市場シェア、2024年・2034年(%)

6 呼吸器薬物送達市場：デバイス別
6.1 主要調査結果
6.2 デバイスセグメント市場魅力度指数
6.3 呼吸器薬物送達のデバイス別市場規模推定と予測
6.4 定量吸入器（MDI）
6.4.1 2024〜2034年の地域別市場規模（US$ Billion）
6.4.2 地域別市場シェア、2024年・2034年(%)
6.5 乾燥粉末吸入器（DPI）
6.5.1 2024〜2034年の地域別市場規模（US$ Billion）
6.5.2 地域別市場シェア、2024年・2034年(%)
6.6 ネブライザー
6.6.1 2024〜2034年の地域別市場規模（US$ Billion）
6.6.2 地域別市場シェア、2024年・2034年(%)
6.7 アクセサリー
6.7.1 2024〜2034年の地域別市場規模（US$ Billion）
6.7.2 地域別市場シェア、2024年・2034年(%)

7 呼吸器薬物送達市場：ネブライザー別
7.1 主要調査結果
7.2 ネブライザーセグメント市場魅力度指数
7.3 ネブライザー別呼吸器薬物送達市場予測、2024年〜2034年
7.4 ソフトミストネブライザー
7.4.1 2024〜2034年の地域別市場規模（US$ Billion）
7.4.2 地域別市場シェア、2024年・2034年(%)
7.5 ジェットネブライザー
7.5.1 2024〜2034年の地域別市場規模（US$ Billion）
7.5.2 地域別市場シェア、2024年・2034年(%)
7.6 超音波ネブライザー
7.6.1 2024〜2034年の地域別市場規模（US$ Billion）
7.6.2 地域別市場シェア、2024年・2034年(%)

8 呼吸器薬物送達市場：キャニスター別
8.1 主要調査結果
8.2 キャニスターセグメント市場魅力度指数
8.3 キャニスター別呼吸器薬物送達市場規模の推定と予測
8.4 プレーンキャニスター
8.4.1 2024〜2034年の地域別市場規模（US$ Billion）
8.4.2 地域別市場シェア、2024年・2034年(%)
8.5 コーティングキャニスター
8.5.1 2024～2034年の地域別市場規模（US$ Billion）
8.5.2 地域別市場シェア、2024年・2034年(%)

9 呼吸器薬物送達市場：用途別
9.1 主要な調査結果
9.2 用途別セグメント市場魅力度指数
9.3 呼吸器薬物送達の用途別市場規模の推定と予測
9.4 喘息
9.4.1 2024〜2034年の地域別市場規模（US$ Billion）
9.4.2 地域別市場シェア、2024年・2034年(%)
9.5 慢性閉塞性肺疾患（COPD）
9.5.1 2024〜2034年の地域別市場規模（US$ Billion）
9.5.2 地域別市場シェア、2024年・2034年 (%)
9.6 嚢胞性線維症
9.6.1 2024〜2034年の地域別市場規模（US$ Billion）
9.6.2 地域別市場シェア、2024年・2034年 (%)
9.7 その他
9.7.1 2024〜2034年の地域別市場規模（US$ Billion）
9.7.2 地域別市場シェア、2024年・2034年 (%)

10 呼吸器薬物送達市場：エンドユーザー別
10.1 主要調査結果
10.2 エンドユーザーセグメント：市場魅力度指数
10.3 エンドユーザー別呼吸器薬物送達市場規模の推定と予測
10.4 在宅介護環境
10.4.1 2024〜2034年の地域別市場規模（US$ Billion）
10.4.2 地域別市場シェア、2024年・2034年(%)
10.5 病院・診療所
10.5.1 2024〜2034年の地域別市場規模（US$ Billion）
10.5.2 地域別市場シェア、2024年・2034年(%)
10.6 その他のエンドユーザー
10.6.1 2024〜2034年の地域別市場規模（US$ Billion）
10.6.2 地域別市場シェア、2024年・2034年(%)

11 呼吸器薬物送達市場分析地域別
11.1 主要な調査結果
11.2 地域別市場規模の推定と予測

12 北米の呼吸器薬物送達市場の分析
12.1 主要な調査結果
12.2 北米の呼吸器薬物送達市場魅力度指数
12.3 北米の呼吸器薬物送達市場の国別推移、2024年、2029年、2034年（US$ Billion）
12.4 北米の呼吸器薬物送達市場市場規模推定と予測：国別
12.5 北米の呼吸器薬物送達市場規模推定と予測：製品別
12.6 北米の呼吸器薬物送達市場規模推定と予測：製剤別
12.7 北米の呼吸器薬物送達市場規模推定と予測：デバイス別
12.8 北米の呼吸器薬物送達市場規模推定と予測：用途別
12.9 北米の呼吸器薬物送達市場規模推定と予測：キャニスター別
12.10 北米の呼吸器薬物送達市場規模推定と予測：ネブライザー別
12.11 北米の呼吸器薬物送達市場規模推定と予測：エンドユーザー別
12.12 アメリカの呼吸器用薬物送達市場分析
12.13 カナダの呼吸器薬物送達市場分析

13 欧州呼吸器薬物送達市場分析
13.1 主要な調査結果
13.2 欧州の呼吸器薬物送達市場魅力度指数
13.3 欧州の呼吸器薬物送達市場の国別推移、2024年、2029年、2034年（US$ Billion）
13.4 欧州の呼吸器薬物送達市場規模推定と予測：国別
13.5 欧州の呼吸器薬物送達市場規模推定と予測：製品別
13.6 欧州の呼吸器薬物送達市場規模推定と予測：製剤別
13.7 欧州の呼吸器薬物送達市場規模推定と予測：デバイス別
13.8 欧州の呼吸器薬物送達市場規模推定と予測：用途別
13.9 欧州の呼吸器薬物送達市場規模推定と予測：キャニスター別
13.10 欧州の呼吸器薬物送達市場規模推定と予測：ネブライザー別
13.11 欧州の呼吸器薬物送達市場規模推定と予測：エンドユーザー別
13.12 ドイツの呼吸器薬物送達市場分析
13.13 イギリスの呼吸器用薬物送達市場分析
13.14 フランスの呼吸器薬物送達市場分析
13.15 イタリアの呼吸器官用薬物送達市場分析
13.16 スペインの呼吸器薬物送達市場分析
13.17 スイスの呼吸器薬物送達市場分析
13.18 ロシアの呼吸器薬物送達市場分析
13.19 その他の欧州の呼吸器薬物送達市場分析

14 アジア太平洋地域の呼吸器薬物送達市場分析
14.1 主要な調査結果
14.2 アジア太平洋地域の呼吸器薬物送達市場魅力度指数
14.3 アジア太平洋地域の呼吸器薬物送達市場の国別市場規模、2024年、2029年、2034年（US$ Billion）
14.4 アジア太平洋地域の呼吸器薬物送達市場規模推定と予測：国別
14.5 アジア太平洋地域の呼吸器薬物送達市場規模推定と予測：製品別
14.6 アジア太平洋地域の呼吸器薬物送達市場規模推定と予測：製剤別
14.7 アジア太平洋地域の呼吸器薬物送達市場規模推定と予測：デバイス別
14.8 アジア太平洋地域の呼吸器薬物送達市場規模推定と予測：用途別
14.9 アジア太平洋地域の呼吸器薬物送達市場規模推定と予測：キャニスター別
14.10 アジア太平洋地域の呼吸器薬物送達市場規模推定と予測：ネブライザー別
14.11 アジア太平洋地域の呼吸器薬物送達市場規模推定と予測：エンドユーザー別
14.12 日本の呼吸器薬物送達市場分析
14.13 中国の呼吸器薬物送達市場分析
14.14 インド呼吸器薬物送達市場分析
14.15 オーストラリアの呼吸器官用薬物送達市場分析
14.16 韓国の呼吸器薬物送達市場分析
14.17 東南アジアの呼吸器薬物送達市場分析
14.18 その他のアジア太平洋地域の呼吸器薬物送達市場分析

15 ラテンアメリカの呼吸器薬物送達市場分析
15.1 主要な調査結果
15.2 ラテンアメリカ呼吸器薬物送達市場魅力度指数
15.3 ラテンアメリカの呼吸器薬物送達市場の国別推移、2024年、2029年、2034年（US$ Billion）
15.4 ラテンアメリカの呼吸器薬物送達市場市場規模推定と予測：国別
15.5 ラテンアメリカの呼吸器薬物送達市場規模推定と予測：製品別
15.6 ラテンアメリカの呼吸器薬物送達市場規模推定と予測：製剤別
15.7 ラテンアメリカの呼吸器薬物送達市場規模推定と予測：デバイス別
15.8 ラテンアメリカの呼吸器薬物送達市場規模推定と予測：用途別
15.9 ラテンアメリカの呼吸器薬物送達市場規模推定と予測：キャニスター別
15.10 ラテンアメリカの呼吸器薬物送達市場規模推定と予測：ネブライザー別
15.11 ラテンアメリカの呼吸器薬物送達市場規模推定と予測：エンドユーザー別
15.12 ブラジルの呼吸器薬物送達市場分析
15.13 メキシコの呼吸器官用薬物送達市場分析
15.14 アルゼンチンの呼吸器薬物送達市場分析
15.15 その他のラテンアメリカの呼吸器薬物送達市場分析

16 MEAの呼吸器薬物送達市場の分析
16.1 主要な調査結果
16.2 MEAの呼吸器官用薬物送達市場の魅力度指数
16.3 MEAの呼吸器薬物送達市場の国別市場規模推移、2024年、2029年、2034年（US$ Billion）
16.4 MEAの呼吸器薬物送達市場規模推定と予測：国別
16.5 MEAの呼吸器薬物送達市場規模推定と予測：製品別
16.6 MEAの呼吸器薬物送達市場規模推定と予測：製剤別
16.7 MEAの呼吸器薬物送達市場規模推定と予測：デバイス別
16.8 MEAの呼吸器薬物送達市場規模推定と予測：用途別
16.9 MEAの呼吸器薬物送達市場規模推定と予測：キャニスター別
16.10 MEAの呼吸器薬物送達市場規模推定と予測：ネブライザー別
16.11 MEAの呼吸器薬物送達市場規模推定と予測：エンドユーザー別
16.12 GCCの呼吸器薬物送達市場分析
16.13 南アフリカの呼吸器官用薬物送達市場の分析
16.14 エジプトの呼吸器薬物送達市場の分析
16.15 その他のMEAの呼吸器官用薬物送達市場の分析

17 企業プロフィール
17.1 競争環境、2022年
17.2 GSK plc
17.2.1 会社概要
17.2.2 会社概要
17.2.3 財務分析
17.2.3.1 純収入、2018-2022年
17.2.3.2 R＆D、2018年～2022年
17.2.3.3 地域市場シェア、2022年
17.2.4 製品ベンチマーク
17.2.5 戦略的展望
17.3 Koninklijke Philips N.V.
17.3.1 会社概要
17.3.2 会社概要
17.3.3 財務分析
17.3.3.1 純収入、2018-2022年
17.3.3.2 R＆D、2018年～2022年
17.3.3.3 セグメント市場シェア、2022年
17.3.3.4 地域市場シェア、2022年
17.3.4 製品ベンチマーク
17.3.5 戦略的展望
17.4 3M
17.4.1 会社概要
17.4.2 会社概要
17.4.3 財務分析
17.4.3.1 純収入、2018-2022年
17.4.3.2 R＆D、2018年～2022年
17.4.3.3 セグメント市場シェア、2022年
17.4.3.4 地域市場シェア、2022年
17.4.4 製品ベンチマーク
17.4.5 戦略的展望
17.5 Boehringer Ingelheim International GmbH
17.5.1 会社概要
17.5.2 会社概要
17.5.3 財務分析
17.5.3.1 純収入、2018-2022年
17.5.3.2 セグメント市場シェア、2022年
17.5.3.3 地域別市場シェア、2022年
17.5.4 製品ベンチマーク
17.5.5 戦略的展望
17.6 AstraZeneca
17.6.1 会社概要
17.6.2 会社概要
17.6.3 財務分析
17.6.3.1 純収入、2018-2022年
17.6.3.2 R＆D、2018年〜2022年
17.6.3.3 セグメント市場シェア、2022年
17.6.3.4 地域市場シェア、2022年
17.6.4 製品ベンチマーク
17.6.5 戦略的展望
17.7 Merck & Co., Inc.
17.7.1 会社概要
17.7.2 会社概要
17.7.3 財務分析
17.7.3.1 純収入、2018-2022年
17.7.3.2 売上高、2018-2022年
17.7.3.3 セグメント市場シェア、2022年
17.7.3.4 地域市場シェア、2022年
17.7.4 製品ベンチマーク
17.7.5 戦略的展望
17.8 Novartis AG
17.8.1 会社概要
17.8.2 会社概要
17.8.3 財務分析
17.8.3.1 純収入、2018-2022年
17.8.3.2 R＆D、2018-2022年
17.8.3.3 セグメント市場シェア、2022年
17.8.3.4 地域市場シェア、2022年
17.8.4 製品ベンチマーク
17.8.5 戦略的展望
17.9 Omron Corporation
17.9.1 会社概要
17.9.2 会社概要
17.9.3 財務分析
17.9.3.1 純収入（2018年～2022年
17.9.3.2 R＆D、2018年～2022年
17.9.3.3 セグメント市場シェア、2022年
17.9.3.4 地域市場シェア、2022年
17.9.4 製品ベンチマーク
17.9.5 戦略的展望
17.10 Sumitomo Pharma Co., Ltd.
17.10.1 会社概要
17.10.2 会社概要
17.10.3 財務分析
17.10.3.1 純収入、2019-2023年
17.10.3.2 売上高、2019-2023年
17.10.4 製品ベンチマーク
17.10.5 戦略的展望
17.11 Teva Pharmaceutical Industries Ltd.
17.11.1 会社概要
17.11.2 会社概要
17.11.3 財務分析
17.11.3.1 純収入、2018-2022年
17.11.3.2 R＆D、2018年〜2022年
17.11.3.3 地域市場シェア、2022年
17.11.4 製品ベンチマーク
17.11.5 戦略的展望
17.12 Cipla Inc.
17.12.1 会社概要
17.12.2 会社概要
17.12.3 財務分析
17.12.3.1 純収入、2019-2023年
17.12.3.2 セグメント市場シェア、2023年
17.12.3.3 地域別市場シェア（2023年
17.12.4 製品ベンチマーク
17.12.5 戦略的展望
17.13 Medisana GmbH
17.13.1 会社概要
17.13.2 会社概要
17.13.3 製品ベンチマーク
17.14 GF Health Products, Inc.
17.14.1 会社概要
17.14.2 会社概要
17.14.3 製品ベンチマーク
17.15 AptarGroup, Inc.
17.15.1 会社概要
17.15.2 会社概要
17.15.3 財務分析
17.15.3.1 純収入、2018-2022年
17.15.3.2 R＆D、2018-2022年
17.15.3.3 セグメント市場シェア、2022年
17.15.3.4 地域市場シェア、2022年
17.15.4 製品ベンチマーク
17.15.5 戦略的展望
17.16 Recipharm AB
17.16.1 会社概要
17.16.2 会社概要
17.16.3 財務分析
17.16.3.1 純収入、2018-2022年
17.16.4 製品ベンチマーク
17.16.5 戦略的展望
17.17 Glenmark Pharmaceuticals Ltd.
17.17.1 会社概要
17.17.2 会社概要
17.17.3 財務分析
17.17.3.1 純収入、2018-2022年
17.17.3.2 地域市場シェア、2022年
17.17.4 製品ベンチマーク
17.18 Vapotherm, Inc.
17.18.1 会社概要
17.18.2 会社概要
17.18.3 財務分析
17.18.3.1 純収入、2018-2022年
17.18.3.2 R＆D、2018年〜2022年
17.18.3.3 セグメント市場シェア、2022年
17.18.3.4 地域市場シェア、2022年
17.18.4 製品ベンチマーク
17.18.5 戦略的展望

18 結論と提言
18.1 Visiongainからの結びの言葉
18.2 市場プレイヤーへの提言

ページTOPに戻る

図表リスト

表の一覧
Table 1 Respiratory Drug Delivery Market Snapshot, 2024 & 2034 (US$ Billion, CAGR %)
Table 2 Respiratory Drug Delivery Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “V” Shaped Recovery
Table 3 Respiratory Drug Delivery Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “U” Shaped Recovery
Table 4 Respiratory Drug Delivery Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “W” Shaped Recovery
Table 5 Respiratory Drug Delivery Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “L” Shaped Recovery
Table 6 Respiratory Drug Delivery Market Forecast by Product, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 7 Formulations Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 8 Devices Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 9 Respiratory Drug Delivery Market by Formulations, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 10 Dry Powder Formulation Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 11 Suspension aerosol Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 12 Solution Aerosol Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 13 Respiratory Drug Delivery Market Forecast by Devices, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 14 Metered Dose Inhaler (MDIs) Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 15 Dry Powder Inhalers (DPIs) Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 16 Nebulizers Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 17 Accessories Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 18 Respiratory Drug Delivery Market by Nebulizers, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 19 Soft Mist Nebulizers Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 20 Jet Nebulizers Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 21 Ultrasonic Nebulizers Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 22 Respiratory Drug Delivery Market Forecast by Canister, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 23 Plain canisters Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 24 Coated canisters Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 25 Respiratory Drug Delivery Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 26 Asthma Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 27 Chronic Obstructive Pulmonary Disease (COPD) Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 28 Cystic Fibrosis Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 29 Others Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 30 Respiratory Drug Delivery Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 31 Homecare Settings Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 32 Hospital & Clinics Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 33 Other End-users Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 34 Respiratory Drug Delivery Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 35 North America Respiratory Drug Delivery Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 36 North America Respiratory Drug Delivery Market Forecast by Product, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 37 North America Respiratory Drug Delivery Market Forecast by Formulation, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 38 North America Respiratory Drug Delivery Market Forecast by Devices, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 39 North America Respiratory Drug Delivery Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 40 North America Respiratory Drug Delivery Market Forecast by Canister, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 41 North America Respiratory Drug Delivery Market Forecast by Nebulizers, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 42 North America Respiratory Drug Delivery Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 43 U.S. Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 44 Canada Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 45 Europe Respiratory Drug Delivery Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 46 Europe Respiratory Drug Delivery Market Forecast by Product, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 47 Europe Respiratory Drug Delivery Market Forecast by Formulation, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 48 Europe Respiratory Drug Delivery Market Forecast by Devices, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 49 Europe Respiratory Drug Delivery Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 50 Europe Respiratory Drug Delivery Market Forecast by Canister, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 51 Europe Respiratory Drug Delivery Market Forecast by Nebulizers, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 52 Europe Respiratory Drug Delivery Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 53 Germany Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 54 UK Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 55 France Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 56 Italy Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 57 Spain Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 58 Switzerland Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 59 Russia Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 60 Rest of Europe Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 61 Asia Pacific Respiratory Drug Delivery Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 62 Asia Pacific Respiratory Drug Delivery Market Forecast by Product, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 63 Asia Pacific Respiratory Drug Delivery Market Forecast by Formulation, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 64 Asia Pacific Respiratory Drug Delivery Market Forecast by Devices, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 65 Asia Pacific Respiratory Drug Delivery Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 66 Asia Pacific Respiratory Drug Delivery Market Forecast by Canister, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 67 Asia Pacific Respiratory Drug Delivery Market Forecast by Nebulizers, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 68 Asia Pacific Respiratory Drug Delivery Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 69 Japan Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 70 China Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 71 India Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 72 Australia Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 73 South Korea Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 74 South East Asia Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 75 Rest of Asia Pacific Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 76 Latin America Respiratory Drug Delivery Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 77 Latin America Respiratory Drug Delivery Market Forecast by Product, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 78 Latin America Respiratory Drug Delivery Market Forecast by Formulation, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 79 Latin America Respiratory Drug Delivery Market Forecast by Devices, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 80 Latin America Respiratory Drug Delivery Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 81 Latin America Respiratory Drug Delivery Market Forecast by Canister, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 82 Latin America Respiratory Drug Delivery Market Forecast by Nebulizers, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 83 Latin America Respiratory Drug Delivery Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 84 Brazil Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 85 Mexico Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 86 Argentina Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 87 Rest of Latin America Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 88 MEA Respiratory Drug Delivery Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 89 MEA Respiratory Drug Delivery Market Forecast by Product, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 90 MEA Respiratory Drug Delivery Market Forecast by Formulation, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 91 MEA Respiratory Drug Delivery Market Forecast by Devices, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 92 MEA Respiratory Drug Delivery Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 93 MEA Respiratory Drug Delivery Market Forecast by Canister, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 94 MEA Respiratory Drug Delivery Market Forecast by Nebulizers, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 95 MEA Respiratory Drug Delivery Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 96 GCC Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 97 South Africa Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 98 Egypt Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 99 Rest of MEA Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 100 GSK plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 GSK plc: Product Benchmarking
Table 102 GSK plc: Strategic Outlook
Table 103 Koninklijke Philips N.V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Koninklijke Philips N.V.: Product Benchmarking
Table 105 Koninklijke Philips N.V.: Strategic Outlook
Table 106 3M: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 3M: Product Benchmarking
Table 108 3M: Strategic Outlook
Table 109 Boehringer Ingelheim International GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 Boehringer Ingelheim International GmbH: Product Benchmarking
Table 111 Boehringer Ingelheim International GmbH: Strategic Outlook
Table 112 AstraZeneca: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 113 AstraZeneca: Product Benchmarking
Table 114 AstraZeneca: Strategic Outlook
Table 115 Merck & Co., Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 116 Merck & Co., Inc.: Product Benchmarking
Table 117 Merck & Co., Inc.: Strategic Outlook
Table 118 Novartis AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 119 Novartis AG: Product Benchmarking
Table 120 Novartis AG: Strategic Outlook
Table 121 Omron Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 122 Omron Corporation.: Product Benchmarking
Table 123 Omron Corporation.: Strategic Outlook
Table 124 Sumitomo Pharma Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 125 Sumitomo Pharma Co., Ltd.: Product Benchmarking
Table 126 Sumitomo Pharma Co., Ltd.: Strategic Outlook
Table 127 Teva Pharmaceutical Industries Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 128 Teva Pharmaceutical Industries Ltd.: Product Benchmarking
Table 129 Teva Pharmaceutical Industries Ltd.: Strategic Outlook
Table 130 Cipla Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 131 Cipla Inc.: Product Benchmarking
Table 132 Cipla Inc.: Strategic Outlook
Table 133 Medisana GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 134 Medisana GmbH: Product Benchmarking
Table 135 GF Health Products, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 136 GF Health Products, Inc.: Product Benchmarking
Table 137 AptarGroup, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 138 AptarGroup, Inc.: Product Benchmarking
Table 139 AptarGroup, Inc.: Strategic Outlook
Table 140 Recipharm AB: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 141 Recipharm AB: Product Benchmarking
Table 142 Recipharm AB: Strategic Outlook
Table 143 Glenmark Pharmaceuticals Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 144 Glenmark Pharmaceuticals Ltd.: Product Benchmarking
Table 145 Vapotherm, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 146 Vapotherm, Inc.: Product Benchmarking
Table 147 Vapotherm, Inc.: Strategic Outlook

図の一覧
Figure 1 Respiratory Drug Delivery Market Segmentation
Figure 2 Respiratory Drug Delivery Market Attractiveness Index by Region
Figure 3 Respiratory Drug Delivery Market by Product: Market Attractiveness Index
Figure 4 Respiratory Drug Delivery Market by Formulation: Market Attractiveness Index
Figure 5 Respiratory Drug Delivery Market by Devices: Market Attractiveness Index
Figure 6 Respiratory Drug Delivery Market by Application: Market Attractiveness Index
Figure 7 Respiratory Drug Delivery Market by Canister: Market Attractiveness Index
Figure 8 Respiratory Drug Delivery Market by Nebulizers: Market Attractiveness Index
Figure 9 Respiratory Drug Delivery Market by End-users: Market Attractiveness Index
Figure 10 Respiratory Drug Delivery Market: Market Dynamics
Figure 11 Hospital Discharge Rates for In-patients with Disease of Respiratory Systems, Per 100,000 Inhabitants by Country, 2021
Figure 12 Respiratory Drug Delivery Market by Region, 2024-2034 (US$ Billion, AGR %): “V” Shaped Recovery
Figure 13 Respiratory Drug Delivery Market by Region, 2024-2034 (US$ Billion, AGR %): “U” Shaped Recovery
Figure 14 Respiratory Drug Delivery Market by Region, 2024-2034 (US$ Billion, AGR %): “W” Shaped Recovery
Figure 15 Respiratory Drug Delivery Market by Region, 2024-2034 (US$ Billion, AGR %): “L” Shaped Recovery
Figure 16 Respiratory Drug Delivery Market: Porter’s Five Forces Analysis
Figure 17 Respiratory Drug Delivery Market: SWOT Analysis
Figure 18 Respiratory Drug Delivery Market: PEST Analysis
Figure 19 Respiratory Drug Delivery Market by Product: Market Attractiveness Index
Figure 20 Respiratory Drug Delivery Market Forecast by Product, 2024-2034 (US$ Billion, AGR %)
Figure 21 Respiratory Drug Delivery Market Share Forecast by Product, 2024, 2029, 2034 (%)
Figure 22 Formulations Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 23 Formulations Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 24 Devices Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 25 Devices Market Share Forecast by Region, 2024 & 2034 (%)
Figure 26 Respiratory Drug Delivery Market by Formulations: Market Attractiveness Index
Figure 27 Respiratory Drug Delivery Market by Type, 2024-2034 (US$ Billion)
Figure 28 Respiratory Drug Delivery Market Share Forecast by Formulations,2024, 2029, 2034 (%)
Figure 29 Dry Powder Formulation Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 30 Dry Powder Formulation Market Share Forecast by Region, 2024 & 2034 (%)
Figure 31 Suspension aerosol Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 32 Suspension aerosol Market Share Forecast by Region, 2024 & 2034 (%)
Figure 33 Solution Aerosol Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 34 Solution Aerosol Market Share Forecast by Region, 2024 & 2034 (%)
Figure 35 Respiratory Drug Delivery Market by Devices: Market Attractiveness Index
Figure 36 Respiratory Drug Delivery Market Forecast by Type, 2024-2034 (US$ Billion)
Figure 37 Respiratory Drug Delivery Market Share Forecast by Type, 2024, 2029, 2034 (%)
Figure 38 Metered Dose Inhaler (MDIs) Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 39 Metered Dose Inhaler (MDIs) Market Share Forecast by Region, 2024 & 2034 (%)
Figure 40 Dry Powder Inhalers (DPIs) Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 41 Dry Powder Inhalers (DPIs) Market Share Forecast by Region, 2024 & 2034 (%)
Figure 42 Nebulizers Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 43 Nebulizers Market Share Forecast by Region, 2024 & 2034 (%)
Figure 44 Accessories Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 45 Accessories Market Share Forecast by Region, 2024 & 2034 (%)
Figure 46 Respiratory Drug Delivery Market by Nebulizers: Market Attractiveness Index
Figure 47 Respiratory Drug Delivery Market by Nebulizers, 2024-2034 (US$ Billion)
Figure 48 Respiratory Drug Delivery Market Share by Nebulizers, 2024, 2029, 2034 (%)
Figure 49 Soft Mist Nebulizers Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 50 Soft Mist Nebulizers Market Share Forecast by Region, 2024 & 2034 (%)
Figure 51 Jet Nebulizers Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 52 Jet Nebulizers Market Share Forecast by Region, 2024 & 2034 (%)
Figure 53 Ultrasonic Nebulizers Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 54 Ultrasonic Nebulizers Market Share Forecast by Region, 2024 & 2034 (%)
Figure 55 Respiratory Drug Delivery Market by Canister: Market Attractiveness Index
Figure 56 Respiratory Drug Delivery Market Forecast by Canister, 2024-2034 (US$ Billion)
Figure 57 Respiratory Drug Delivery Market Share Forecast by Canister, 2024, 2029, 2034 (%)
Figure 58 Plain canisters Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 59 Plain canisters Market Share Forecast by Region, 2024 & 2034 (%)
Figure 60 Coated canisters Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 61 Coated canisters Market Share Forecast by Region, 2024 & 2034 (%)
Figure 62 Respiratory Drug Delivery Market by Application: Market Attractiveness Index
Figure 63 Respiratory Drug Delivery Market Forecast by Application, 2024-2034 (US$ Billion)
Figure 64 Respiratory Drug Delivery Market Share Forecast by Application, 2024, 2029, 2034 (%)
Figure 65 Asthma Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 66 Asthma Market Share Forecast by Region, 2024 & 2034 (%)
Figure 67 Chronic Obstructive Pulmonary Disease (COPD) Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 68 Chronic Obstructive Pulmonary Disease (COPD) Market Share Forecast by Region, 2024 & 2034 (%)
Figure 69 Cystic Fibrosis Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 70 Cystic Fibrosis Market Share Forecast by Region, 2024 & 2034 (%)
Figure 71 Others Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 72 Others Market Share Forecast by Region, 2024 & 2034 (%)
Figure 73 Respiratory Drug Delivery Market by End-users: Market Attractiveness Index
Figure 74 Respiratory Drug Delivery Market Forecast by End-users, 2024-2034 (US$ Billion)
Figure 75 Respiratory Drug Delivery Market Share Forecast by End-users, 2024, 2029, 2034 (%)
Figure 76 Homecare Settings Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 77 Homecare Settings Market Share Forecast by Region, 2024 & 2034 (%)
Figure 78 Hospital & Clinics Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 79 Hospital & Clinics Market Share Forecast by Region, 2024 & 2034 (%)
Figure 80 Other End-users Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 81 Others Market Share Forecast by Region, 2024 & 2034 (%)
Figure 82 Respiratory Drug Delivery Market Forecast by Region 2024 and 2034 (Revenue, CAGR%)
Figure 83 Respiratory Drug Delivery Market Share Forecast by Region 2024, 2029, 2034 (%)
Figure 84 Respiratory Drug Delivery Market by Region, 2024-2034 (US$ Billion, AGR %)
Figure 85 North America Respiratory Drug Delivery Market Attractiveness Index
Figure 86 North America Respiratory Drug Delivery Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 87 North America Respiratory Drug Delivery Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 88 North America Respiratory Drug Delivery Market Share Forecast by Country, 2024 & 2034 (%)
Figure 89 North America Respiratory Drug Delivery Market Forecast by Product, 2024-2034 (US$ Billion, AGR %)
Figure 90 North America Respiratory Drug Delivery Market Share Forecast by Product, 2024 & 2034 (%)
Figure 91 North America Respiratory Drug Delivery Market Forecast by Formulation, 2024-2034 (US$ Billion, AGR %)
Figure 92 North America Respiratory Drug Delivery Market Share Forecast by Formulation, 2024 & 2034 (%)
Figure 93 North America Respiratory Drug Delivery Market Forecast by Devices, 2024-2034 (US$ Billion, AGR %)
Figure 94 North America Respiratory Drug Delivery Market Share Forecast by Devices, 2024 & 2034 (%)
Figure 95 North America Respiratory Drug Delivery Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 96 North America Respiratory Drug Delivery Market Share Forecast by Application, 2024 & 2034 (%)
Figure 97 North America Respiratory Drug Delivery Market Forecast by Canister, 2024-2034 (US$ Billion, AGR %)
Figure 98 North America Respiratory Drug Delivery Market Share Forecast by Canister, 2024 & 2034 (%)
Figure 99 North America Respiratory Drug Delivery Market Forecast by Nebulizers, 2024-2034 (US$ Billion, AGR %)
Figure 100 North America Respiratory Drug Delivery Market Share Forecast by Nebulizers, 2024 & 2034 (%)
Figure 101 North America Respiratory Drug Delivery Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
Figure 102 North America Respiratory Drug Delivery Market Share Forecast by End-users, 2024 & 2034 (%)
Figure 103 U.S. Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 104 Canada Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 105 Europe Respiratory Drug Delivery Market Attractiveness Index
Figure 106 Europe Respiratory Drug Delivery Market by Country, 2024, 2029 & 2034 (US$ Billion)
Figure 107 Europe Respiratory Drug Delivery Market Forecast by Country, 2024-2034 (US$ Billion)
Figure 108 Europe Respiratory Drug Delivery Market Share Forecast by Country, 2024 & 2034 (%)
Figure 109 Europe Respiratory Drug Delivery Market Forecast by Product, 2024-2034 (US$ Billion)
Figure 110 Europe Respiratory Drug Delivery Market Share Forecast by Product, 2024 & 2034 (%)
Figure 111 Europe Respiratory Drug Delivery Market Forecast by Formulation, 2024-2034 (US$ Billion)
Figure 112 Europe Respiratory Drug Delivery Market Share Forecast by Formulation, 2024 & 2034 (%)
Figure 113 Europe Respiratory Drug Delivery Market Forecast by Devices, 2024-2034 (US$ Billion)
Figure 114 Europe Respiratory Drug Delivery Market Share Forecast by Devices, 2024 & 2034 (%)
Figure 115 Europe Respiratory Drug Delivery Market Forecast by Application, 2024-2034 (US$ Billion)
Figure 116 Europe Respiratory Drug Delivery Market Share Forecast by Application, 2024 & 2034(%)
Figure 117 Europe Respiratory Drug Delivery Market Forecast by Canister, 2024-2034 (US$ Billion)
Figure 118 Europe Respiratory Drug Delivery Market Share Forecast by Canister, 2024 & 2034(%)
Figure 119 Europe Respiratory Drug Delivery Market Forecast by Nebulizers, 2024-2034 (US$ Billion)
Figure 120 Europe Respiratory Drug Delivery Market Share Forecast by Nebulizers, 2024 & 2034(%)
Figure 121 Europe Respiratory Drug Delivery Market Forecast by End-users, 2024-2034 (US$ Billion)
Figure 122 Europe Respiratory Drug Delivery Market Share Forecast by End-users, 2024 & 2034(%)
Figure 123 Germany Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 124 UK Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 125 France Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 126 Italy Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 127 Spain Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 128 Switzerland Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 129 Russia Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 130 Rest of Europe Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 131 Asia Pacific Respiratory Drug Delivery Market Attractiveness Index
Figure 132 Asia Pacific Respiratory Drug Delivery Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 133 Asia Pacific Respiratory Drug Delivery Market Forecast by Country, 2024-2034 (US$ Billion)
Figure 134 Asia Pacific Respiratory Drug Delivery Market Share Forecast by Country, 2024 & 2034 (%)
Figure 135 Asia Pacific Respiratory Drug Delivery Market Forecast by Product, 2024-2034 (US$ Billion)
Figure 136 Asia Pacific Respiratory Drug Delivery Market Share Forecast by Product, 2024 & 2034 (%)
Figure 137 Asia Pacific Respiratory Drug Delivery Market Forecast by Formulation, 2024-2034 (US$ Billion)
Figure 138 Asia Pacific Respiratory Drug Delivery Market Share Forecast by Formulation, 2024 & 2034 (%)
Figure 139 Asia Pacific Respiratory Drug Delivery Market Forecast by Devices, 2024-2034 (US$ Billion)
Figure 140 Asia Pacific Respiratory Drug Delivery Market Share Forecast by Devices, 2024 & 2034 (%)
Figure 141 Asia Pacific Respiratory Drug Delivery Market Forecast by Application, 2024-2034 (US$ Billion)
Figure 142 Asia Pacific Respiratory Drug Delivery Market Share Forecast by Application, 2024 & 2034 (%)
Figure 143 Asia Pacific Respiratory Drug Delivery Market Forecast by Canister, 2024-2034 (US$ Billion)
Figure 144 Asia Pacific Respiratory Drug Delivery Market Share Forecast by Canister, 2024 & 2034 (%)
Figure 145 Asia Pacific Respiratory Drug Delivery Market Forecast by Nebulizers, 2024-2034 (US$ Billion)
Figure 146 Asia Pacific Respiratory Drug Delivery Market Share Forecast by Nebulizers, 2024 & 2034 (%)
Figure 147 Asia Pacific Respiratory Drug Delivery Market Forecast by End-users, 2024-2034 (US$ Billion)
Figure 148 Asia Pacific Respiratory Drug Delivery Market Share Forecast by End-users, 2024 & 2034 (%)
Figure 149 Japan Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 150 China Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 151 India Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 152 Australia Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 153 South Korea Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 154 South East Asia Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 155 Rest of Asia Pacific Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 156 Latin America Respiratory Drug Delivery Market Attractiveness Index
Figure 157 Latin America Respiratory Drug Delivery Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 158 Latin America Respiratory Drug Delivery Market Forecast by Country, 2024-2034 (US$ Billion)
Figure 159 Latin America Respiratory Drug Delivery Market Share Forecast by Country, 2024 & 2034 (%)
Figure 160 Latin America Respiratory Drug Delivery Market Forecast by Product, 2024-2034 (US$ Billion)
Figure 161 Latin America Respiratory Drug Delivery Market Share Forecast by Product, 2024 & 2034 (%)
Figure 162 Latin America Respiratory Drug Delivery Market Forecast by Formulation, 2024-2034 (US$ Billion)
Figure 163 Latin America Respiratory Drug Delivery Market Share Forecast by Formulation, 2024 & 2034 (%)
Figure 164 Latin America Respiratory Drug Delivery Market Forecast by Devices, 2024-2034 (US$ Billion)
Figure 165 Latin America Respiratory Drug Delivery Market Share Forecast by Devices, 2024 & 2034 (%)
Figure 166 Latin America Respiratory Drug Delivery Market Forecast by Application, 2024-2034 (US$ Billion)
Figure 167 Latin America Respiratory Drug Delivery Market Share Forecast by Application, 2024 & 2034 (%)
Figure 168 Latin America Respiratory Drug Delivery Market Forecast by Canister, 2024-2034 (US$ Billion)
Figure 169 Latin America Respiratory Drug Delivery Market Share Forecast by Canister, 2024 & 2034 (%)
Figure 170 Latin America Respiratory Drug Delivery Market Forecast by Nebulizers, 2024-2034 (US$ Billion)
Figure 171 Latin America Respiratory Drug Delivery Market Share Forecast by Nebulizers, 2024 & 2034 (%)
Figure 172 Latin America Respiratory Drug Delivery Market Forecast by End-users, 2024-2034 (US$ Billion)
Figure 173 Latin America Respiratory Drug Delivery Market Share Forecast by End-users, 2024 & 2034 (%)
Figure 174 Brazil Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 175 Mexico Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 176 Argentina Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 177 Rest of Latin America Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 178 MEA Respiratory Drug Delivery Market Attractiveness Index
Figure 179 MEA Respiratory Drug Delivery Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 180 MEA Respiratory Drug Delivery Market Forecast by Country, 2024-2034 (US$ Billion)
Figure 181 MEA Respiratory Drug Delivery Market Share Forecast by Country, 2024 & 2034 (%)
Figure 182 MEA Respiratory Drug Delivery Market Forecast by Product, 2024-2034 (US$ Billion)
Figure 183 MEA Respiratory Drug Delivery Market Share Forecast by Product, 2024 & 2034 (%)
Figure 184 MEA Respiratory Drug Delivery Market Forecast by Formulation, 2024-2034 (US$ Billion)
Figure 185 MEA Respiratory Drug Delivery Market Share Forecast by Formulation, 2024 & 2034 (%)
Figure 186 MEA Respiratory Drug Delivery Market Forecast by Devices, 2024-2034 (US$ Billion)
Figure 187 MEA Respiratory Drug Delivery Market Share Forecast by Devices, 2024 & 2034 (%)
Figure 188 MEA Respiratory Drug Delivery Market Forecast by Application, 2024-2034 (US$ Billion)
Figure 189 MEA Respiratory Drug Delivery Market Share Forecast by Application, 2024 & 2034 (%)
Figure 190 MEA Respiratory Drug Delivery Market Forecast by Canister, 2024-2034 (US$ Billion)
Figure 191 MEA Respiratory Drug Delivery Market Share Forecast by Canister, 2024 & 2034 (%)
Figure 192 MEA Respiratory Drug Delivery Market Forecast by Nebulizers, 2024-2034 (US$ Billion)
Figure 193 MEA Respiratory Drug Delivery Market Share Forecast by Nebulizers, 2024 & 2034 (%)
Figure 194 MEA Respiratory Drug Delivery Market Forecast by End-users, 2024-2034 (US$ Billion)
Figure 195 MEA Respiratory Drug Delivery Market Share Forecast by End-users, 2024 & 2034 (%)
Figure 196 GCC Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 197 South Africa Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 198 Egypt Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 199 Rest of MEA Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 200 Respiratory Drug Delivery Market: Company Share/Ranking, 2022
Figure 201 GSK plc: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 202 GSK plc: R&D, 2018-2022 (US$ Million, AGR %)
Figure 203 GSK plc: Regional Market Shares, 2022
Figure 204 Koninklijke Philips N.V.: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 205 Koninklijke Philips N.V.: R&D, 2018-2022 (US$ Million, AGR %)
Figure 206 Koninklijke Philips N.V.: Segment Market Shares, 2022
Figure 207 Koninklijke Philips N.V.: Regional Market Shares, 2022
Figure 208 3M: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 209 3M: R&D, 2018-2022 (US$ Million, AGR %)
Figure 210 3M: Segment Market Shares, 2022
Figure 211 3M: Regional Market Shares, 2022
Figure 212 Boehringer Ingelheim International GmbH: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 213 Boehringer Ingelheim International GmbH: Segment Market Shares, 2022
Figure 214 Boehringer Ingelheim International GmbH: Regional Market Shares, 2022
Figure 215 AstraZeneca: Net Revenue, 2018-2022 (US$ Million, AGR (%)
Figure 216 AstraZeneca: R&D, 2018-2022 (US$ Million, AGR %)
Figure 217 AstraZeneca: Segment Market Shares, 2022
Figure 218 AstraZeneca: Regional Market Shares, 2022
Figure 219 Merck & Co., Inc.: Net Revenue, 2018-2022 (US$ Million, AGR (%)
Figure 220 Merck & Co., Inc.: R&D, 2018-2022 (US$ Million, AGR %)
Figure 221 Merck & Co., Inc.: Segment Market Shares, 2022
Figure 222 Merck & Co., Inc.: Regional Market Shares, 2022
Figure 223 Novartis AG: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 224 Novartis AG: R&D, 2018-2022 (US$ Million, AGR %)
Figure 225 Novartis AG: Segment Market Shares, 2022
Figure 226 Novartis AG: Regional Market Shares, 2022
Figure 227 Omron Corporation: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 228 Omron Corporation: R&D, 2018-2022 (US$ Million, AGR %)
Figure 229 Omron Corporation: Segment Market Shares, 2022
Figure 230 Omron Corporation: Regional Market Shares, 2022
Figure 231 Sumitomo Pharma Co., Ltd.: Net Revenue, 2019-2023 (US$ Million, AGR %)
Figure 232 Sumitomo Pharma Co., Ltd.: R&D, 2019-2023 (US$ Million, AGR %)
Figure 233 Teva Pharmaceutical Industries Ltd.: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 234 Teva Pharmaceutical Industries Ltd.: R&D, 2018-2022 (US$ Million, AGR %)
Figure 235 Teva Pharmaceutical Industries Ltd.: Regional Market Shares, 2022
Figure 236 Cipla Inc.: Net Revenue, 2019-2023 (US$ Million, AGR %)
Figure 237 Cipla Inc.: Segment Market Shares, 2023
Figure 238 Cipla Inc.: Regional Market Shares, 2023
Figure 239 AptarGroup, Inc.: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 240 AptarGroup, Inc.: R&D, 2018-2022 (US$ Million, AGR %)
Figure 241 AptarGroup, Inc.: Segment Market Shares, 2022
Figure 242 AptarGroup, Inc.: Regional Market Shares, 2022
Figure 243 Recipharm AB: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 244 Glenmark Pharmaceuticals Ltd.: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 245 Glenmark Pharmaceuticals Ltd.: Regional Market Shares, 2022
Figure 246 Vapotherm, Inc.: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 247 Vapotherm, Inc.: R&D, 2018-2022 (US$ Million, AGR %)
Figure 248 Vapotherm, Inc.: Segment Market Shares, 2022
Figure 249 Vapotherm, Inc.: Regional Market Shares, 2022

ページTOPに戻る

Table of Contents
List of Tables/Graphs

Summary

Report Details

The Respiratory Drug Delivery Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Launch of Smart/Digital Inhalers and Outbreak of COVID-19 Pandemic Projected to Spur Industry Growth

At present, smart inhalers just record the patient’s actuation, which is a time and date stamp, during use. Numerous firms are producing devices that can be connected to inhalers that are currently in use. Leading the way in this trend are the American organisations Propeller Health and Adherium, both of which were founded in New Zealand. Data from clinical studies conducted by both firms indicate that patients might gain advantages from utilising their products. In another instance, Innovate UK provided co-funding to Aseptika, a firm that specialises in developing intelligent inhalers for patients with chronic respiratory conditions, in January 2023. With integrated 5G mobile connectivity, the company’s third-generation smart inhaler tracker will be developed further with the help of the Smart Award.

Since COVID-19 affects particular lung tissues, bronchodilators are frequently utilised as part of therapy. Nebulizers may encourage the creation of aerosolized virus in patients, which could worsen the spread of COVID-19. For this reason, the use of MDI is advised. There is a growing medical need for COVID-19 treatment, which is creating a shortage of inhalers. For instance, a strategic agreement was reached in October 2022 between GenScript ProBio and Hibiocy Co. Ltd. to accelerate the development of COVITRAP, a respiratory-care medical device that includes a human antibody for COVID-19. By preventing the COVID-19 virus from sticking to the nasal cavity’s interior surfaces, COVITRAP, a nasal spray, can reduce the amount of virus present in the nasal cavity. Following approval by the Thai FDA, COVITRAP was formally released onto the Thai market. This indicates that in reaction to the COVID-19 pandemic, there has been an increased demand for respiratory medicine delivery technologies to treat patients with the virus as well as those suffering from bronchitis, asthma, and other respiratory conditions.

Stringent Government Regulations Likely to Challenge Industry Growth

The FDA usually goes through lengthy and laborious processes to approve medical devices, drugs, and drug technology before a product can be sold. This usually poses a challenge to companies that conduct intensive R&D in order to launch new products on the market. Authorities rigorously verify the product’s safety and use before making it available for sale to the general public. As a drug-device combination of 97 items, MDIs and DPIs are mixed products subject to the current good manufacturing practice (CGMP) requirements for pharmaceuticals and devices. In particular, they apply to all MDIs and DPIs that have a device component that is subject to design controls (21 CFR 820.30). Industry guidelines on pharmaceutical development, which are founded on the concepts of quality via design, address the processes of product design and development. Even though quality via 110 design and design controls have the same features and objectives, the Quality System 111 Regulation (21 CFR 820) for devices provides design requirements.

What Questions Should You Ask Before Buying a Market Research Report?

How is the respiratory drug delivery market evolving?
What is driving and restraining the respiratory drug delivery market?
How will each point of care diagnostic submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
How will the market shares for each respiratory drug delivery submarket develop from 2024 to 2034?
What will be the main driver for the overall market from 2024 to 2034?
Will leading respiratory drug delivery markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
Who are the leading players and what are their prospects over the forecast period?
What are the respiratory drug delivery projects for these leading companies?
How will the industry evolve during the period between 2024 and 2034? What are the implications of respiratory drug delivery projects taking place now and over the next 10 years?
Is there a greater need for product commercialisation to further scale the respiratory drug delivery market?
Where is the respiratory drug delivery market heading and how can you ensure you are at the forefront of the market?
What are the best investment options for new product and service lines?
What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Respiratory Drug Delivery market today, and over the next 10 years:

Our 348-page report provides 147 tables, 249 charts, and graphs exclusively to you.
The report highlights key lucrative areas in the industry so you can target them – NOW.
It contains in-depth analysis of global, regional and national sales and growth.
It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the respiratory drug delivery market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects

In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.
You will find original analyses, with business outlooks and developments.
Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), impact of rising respiratory drug delivery prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Product

Formulations
Devices

Formulations

Dry Powder
Suspension Aerosol
Solution Aerosol

Devices

Metered Dose Inhalers (MDIs)
Dry Powder Inhalers (DPIs)
Nebulizers
Accessories

Nebulizers

Soft Mist Nebulizers
Jet Nebulizers
Ultrasonic Nebulizers

Canister

Plain Canisters
Coated Canister

Application

Asthma
COPD
Cystic Fibrosis
Others

End-users

Homecare settings
Hospitals & Clinics
Other End-users

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 25 leading national markets:

North America

U.S.
Canada

Europe

Germany
UK
France
Italy
Spain
Switzerland
Russia
Rest of Europe

Asia Pacific

China
Japan
India
Australia
South Korea
South East Asia
Rest of Asia Pacific

Latin America

Brazil
Mexico
Argentina
Rest of Latin America

MEA

GCC
South Africa
Egypt
Rest of MEA

The report also includes profiles and for some of the leading companies in the Respiratory Drug Delivery Market, 2024 to 2034, with a focus on this segment of these companies’ operations.

Leading companies profiled in the report

3M
AptarGroup Inc.
AstraZeneca
Boehringer Ingelheim International GmbH
Cipla Inc.
GF Health Products Inc.
Glenmark Pharmaceuticals Ltd.
GSK plc.
Koninklijke Philips N.V.
Medisana GmbH
Merck & Co.
Novartis AG
Omron Corporation
Recipharm AB
Sumitomo Pharma Co., Ltd.
Teva Pharmaceutical Industries Ltd.
Vapotherm

Overall world revenue for Respiratory Drug Delivery Market, 2024 to 2034 in terms of value the market will surpass US$67.0 billion in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Respiratory Drug Delivery Market, 2024 to 2034 report help you?

In summary, our 340+ page report provides you with the following knowledge:

Revenue forecasts to 2034 for Respiratory Drug Delivery Market, 2024 to 2034, with forecasts for product, formulations, devices, nebulizers, canister, application and end-users, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
Revenue forecasts to 2034 for five regional and 25 key national markets – See forecasts for the Respiratory Drug Delivery Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, Spain, Switzerland, Russia, China, India, Japan, Australia, South Korea, South East Asia, Argentina, GCC, South Africa, and Egypt among other prominent economies.
Prospects for established firms and those seeking to enter the market – including company profiles for 17 of the major companies involved in the Respiratory Drug Delivery Market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the respiratory drug delivery Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Respiratory Drug Delivery Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.2 Technological Advancements in Respiratory Drug Delivery Expected to Boost the Market
3.2.1.3 Outbreak of COVID-19 Pandemic
3.2.1.4 Growing Support of Government and NGOs for Respiratory Diseases Healthcare Awareness
3.2.1.5 Launch of Smart/Digital Inhalers will Propel the Adoption of Advanced Drug Delivery Devices
3.2.2 Market Restraining Factors
3.2.2.1 Stringent Government Regulations is Expected to Hinder the Market Growth
3.2.2.2 Intense Competition Among Vendors is Projected to Restrain the Market Growth
3.2.2.3 Pricing Pressure a Major Challenge
3.2.2.4 Challenges Associated with Respiratory Drugs Delivery Design
3.2.3 Market Opportunities
3.2.3.1 Trends in Metered Dose Inhaler (MDI) Technology is Expected to Propel the Market in Near Future
3.2.3.2 Mergers, Agreements, and Acquisitions by Market Players is a Major Trend Witnessed in the Market
3.2.3.3 Dry Powder Drug Delivery Product Innovation Driving the Adoption of Respiratory Drugs
3.2.3.4 Increase in Research and Development in Pulmonary Drug Delivery System
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Supplier: High
3.4.2 Threat of New Entrants: Moderate
3.4.3 Bargaining Power of Buyer: Moderate
3.4.4 Competitive Rivalry: High
3.4.5 Threat of Substitutes: Moderate
3.5 SWOT Analysis
3.6 PEST Analysis
3.6.1 Political Factors Impacting Respiratory Drug Delivery Market
3.6.2 Economic Factors Impacting Respiratory Drug Delivery Market
3.6.3 Social Factors Impacting Respiratory Drug Delivery Market
3.6.4 Technological Factors Impacting Respiratory Drug Delivery Market

4 Respiratory Drug Delivery Market Analysis by Product
4.1 Key Findings
4.2 Product Segment: Market Attractiveness Index
4.3 Respiratory Drug Delivery Market Size Estimation and Forecast by Product
4.4 Formulations
4.4.1 Market Size by Region, 2024-2034 (US$ Billion)
4.4.2 Market Share by Region, 2024 & 2034 (%)
4.5 Devices
4.5.1 Market Size by Region, 2024-2034 (US$ Billion)
4.5.2 Market Share by Region, 2024 & 2034 (%)

5 Respiratory Drug Delivery Market by Formulations
5.1 Key Findings
5.2 Formulations Segment: Market Attractiveness Index
5.3 Respiratory Drug Delivery Market, by Formulations
5.4 Dry Powder Formulation
5.4.1 Market Size by Region, 2024-2034 (US$ Billion)
5.4.2 Market Share by Region, 2024 & 2034 (%)
5.5 Suspension Aerosol
5.5.1 Market Size by Region, 2024-2034 (US$ Billion)
5.5.2 Market Share by Region, 2024 & 2034 (%)
5.6 Solution Aerosol
5.6.1 Market Size by Region, 2024-2034 (US$ Billion)
5.6.2 Market Share by Region, 2024 & 2034 (%)

6 Respiratory Drug Delivery Market by Devices
6.1 Key Findings
6.2 Devices Segment: Market Attractiveness Index
6.3 Respiratory Drug Delivery Market Size Estimation and Forecast by Devices
6.4 Metered Dose Inhalers (MDIs)
6.4.1 Market Size by Region, 2024-2034 (US$ Billion)
6.4.2 Market Share by Region, 2024 & 2034 (%)
6.5 Dry Powder Inhalers (DPIs)
6.5.1 Market Size by Region, 2024-2034 (US$ Billion)
6.5.2 Market Share by Region, 2024 & 2034 (%)
6.6 Nebulizers
6.6.1 Market Size by Region, 2024-2034 (US$ Billion)
6.6.2 Market Share by Region, 2024 & 2034 (%)
6.7 Accessories
6.7.1 Market Size by Region, 2024-2034 (US$ Billion)
6.7.2 Market Share by Region, 2024 & 2034 (%)

7 Respiratory Drug Delivery Market by Nebulizers
7.1 Key Findings
7.2 Nebulizers Segment: Market Attractiveness Index
7.3 Respiratory Drug Delivery Market by Nebulizers Forecast, 2024-2034
7.4 Soft Mist Nebulizers
7.4.1 Market Size by Region, 2024-2034 (US$ Billion)
7.4.2 Market Share by Region, 2024 & 2034 (%)
7.5 Jet Nebulizers
7.5.1 Market Size by Region, 2024-2034 (US$ Billion)
7.5.2 Market Share by Region, 2024 & 2034 (%)
7.6 Ultrasonic Nebulizers
7.6.1 Market Size by Region, 2024-2034 (US$ Billion)
7.6.2 Market Share by Region, 2024 & 2034 (%)

8 Respiratory Drug Delivery Market by Canister
8.1 Key Findings
8.2 Canister Segment: Market Attractiveness Index
8.3 Respiratory Drug Delivery Market Size Estimation and Forecast by Canister
8.4 Plain canisters
8.4.1 Market Size by Region, 2024-2034 (US$ Billion)
8.4.2 Market Share by Region, 2024 & 2034 (%)
8.5 Coated canisters
8.5.1 Market Size by Region, 2024-2034 (US$ Billion)
8.5.2 Market Share by Region, 2024 & 2034 (%)

9 Respiratory Drug Delivery Market by Application
9.1 Key Findings
9.2 Application Segment: Market Attractiveness Index
9.3 Respiratory Drug Delivery Market Size Estimation and Forecast by Application
9.4 Asthma
9.4.1 Market Size by Region, 2024-2034 (US$ Billion)
9.4.2 Market Share by Region, 2024 & 2034 (%)
9.5 Chronic Obstructive Pulmonary Disease (COPD)
9.5.1 Market Size by Region, 2024-2034 (US$ Billion)
9.5.2 Market Share by Region, 2024 & 2034 (%)
9.6 Cystic Fibrosis
9.6.1 Market Size by Region, 2024-2034 (US$ Billion)
9.6.2 Market Share by Region, 2024 & 2034 (%)
9.7 Others
9.7.1 Market Size by Region, 2024-2034 (US$ Billion)
9.7.2 Market Share by Region, 2024 & 2034 (%)

10 Respiratory Drug Delivery Market by End-users
10.1 Key Findings
10.2 End-users Segment: Market Attractiveness Index
10.3 Respiratory Drug Delivery Market Size Estimation and Forecast by End-users
10.4 Homecare Settings
10.4.1 Market Size by Region, 2024-2034 (US$ Billion)
10.4.2 Market Share by Region, 2024 & 2034 (%)
10.5 Hospital & Clinics
10.5.1 Market Size by Region, 2024-2034 (US$ Billion)
10.5.2 Market Share by Region, 2024 & 2034 (%)
10.6 Other End-users
10.6.1 Market Size by Region, 2024-2034 (US$ Billion)
10.6.2 Market Share by Region, 2024 & 2034 (%)

11 Respiratory Drug Delivery Market Analysis by Region
11.1 Key Findings
11.2 Regional Market Size Estimation and Forecast

12 North America Respiratory Drug Delivery Market Analysis
12.1 Key Findings
12.2 North America Respiratory Drug Delivery Market Attractiveness Index
12.3 North America Respiratory Drug Delivery Market by Country, 2024, 2029 & 2034 (US$ Billion)
12.4 North America Respiratory Drug Delivery Market Size Estimation and Forecast by Country
12.5 North America Respiratory Drug Delivery Market Size Estimation and Forecast by Product
12.6 North America Respiratory Drug Delivery Market Size Estimation and Forecast by Formulation
12.7 North America Respiratory Drug Delivery Market Size Estimation and Forecast by Devices
12.8 North America Respiratory Drug Delivery Market Size Estimation and Forecast by Application
12.9 North America Respiratory Drug Delivery Market Size Estimation and Forecast by Canister
12.10 North America Respiratory Drug Delivery Market Size Estimation and Forecast by Nebulizers
12.11 North America Respiratory Drug Delivery Market Size Estimation and Forecast by End-users
12.12 U.S. Respiratory Drug Delivery Market Analysis
12.13 Canada Respiratory Drug Delivery Market Analysis

13 Europe Respiratory Drug Delivery Market Analysis
13.1 Key Findings
13.2 Europe Respiratory Drug Delivery Market Attractiveness Index
13.3 Europe Respiratory Drug Delivery Market by Country, 2024, 2029 & 2034 (US$ Billion)
13.4 Europe Respiratory Drug Delivery Market Size Estimation and Forecast by Country
13.5 Europe Respiratory Drug Delivery Market Size Estimation and Forecast by Product
13.6 Europe Respiratory Drug Delivery Market Size Estimation and Forecast by Formulation
13.7 Europe Respiratory Drug Delivery Market Size Estimation and Forecast by Devices
13.8 Europe Respiratory Drug Delivery Market Size Estimation and Forecast by Application
13.9 Europe Respiratory Drug Delivery Market Size Estimation and Forecast by Canister
13.10 Europe Respiratory Drug Delivery Market Size Estimation and Forecast by Nebulizers
13.11 Europe Respiratory Drug Delivery Market Size Estimation and Forecast by End-users
13.12 Germany Respiratory Drug Delivery Market Analysis
13.13 UK Respiratory Drug Delivery Market Analysis
13.14 France Respiratory Drug Delivery Market Analysis
13.15 Italy Respiratory Drug Delivery Market Analysis
13.16 Spain Respiratory Drug Delivery Market Analysis
13.17 Switzerland Respiratory Drug Delivery Market Analysis
13.18 Russia Respiratory Drug Delivery Market Analysis
13.19 Rest of Europe Respiratory Drug Delivery Market Analysis

14 Asia Pacific Respiratory Drug Delivery Market Analysis
14.1 Key Findings
14.2 Asia Pacific Respiratory Drug Delivery Market Attractiveness Index
14.3 Asia Pacific Respiratory Drug Delivery Market by Country, 2024, 2029 & 2034 (US$ Billion)
14.4 Asia Pacific Respiratory Drug Delivery Market Size Estimation and Forecast by Country
14.5 Asia Pacific Respiratory Drug Delivery Market Size Estimation and Forecast by Product
14.6 Asia Pacific Respiratory Drug Delivery Market Size Estimation and Forecast by Formulation
14.7 Asia Pacific Respiratory Drug Delivery Market Size Estimation and Forecast by Devices
14.8 Asia Pacific Respiratory Drug Delivery Market Size Estimation and Forecast by Application
14.9 Asia Pacific Respiratory Drug Delivery Market Size Estimation and Forecast by Canister
14.10 Asia Pacific Respiratory Drug Delivery Market Size Estimation and Forecast by Nebulizers
14.11 Asia Pacific Respiratory Drug Delivery Market Size Estimation and Forecast by End-users
14.12 Japan Respiratory Drug Delivery Market Analysis
14.13 China Respiratory Drug Delivery Market Analysis
14.14 India Respiratory Drug Delivery Market Analysis
14.15 Australia Respiratory Drug Delivery Market Analysis
14.16 South Korea Respiratory Drug Delivery Market Analysis
14.17 South East Asia Respiratory Drug Delivery Market Analysis
14.18 Rest of Asia Pacific Respiratory Drug Delivery Market Analysis

15 Latin America Respiratory Drug Delivery Market Analysis
15.1 Key Findings
15.2 Latin America Respiratory Drug Delivery Market Attractiveness Index
15.3 Latin America Respiratory Drug Delivery Market by Country, 2024, 2029 & 2034 (US$ Billion)
15.4 Latin America Respiratory Drug Delivery Market Size Estimation and Forecast by Country
15.5 Latin America Respiratory Drug Delivery Market Size Estimation and Forecast by Product
15.6 Latin America Respiratory Drug Delivery Market Size Estimation and Forecast by Formulation
15.7 Latin America Respiratory Drug Delivery Market Size Estimation and Forecast by Devices
15.8 Latin America Respiratory Drug Delivery Market Size Estimation and Forecast by Application
15.9 Latin America Respiratory Drug Delivery Market Size Estimation and Forecast by Canister
15.10 Latin America Respiratory Drug Delivery Market Size Estimation and Forecast by Nebulizers
15.11 Latin America Respiratory Drug Delivery Market Size Estimation and Forecast by End-users
15.12 Brazil Respiratory Drug Delivery Market Analysis
15.13 Mexico Respiratory Drug Delivery Market Analysis
15.14 Argentina Respiratory Drug Delivery Market Analysis
15.15 Rest of Latin America Respiratory Drug Delivery Market Analysis

16 MEA Respiratory Drug Delivery Market Analysis
16.1 Key Findings
16.2 MEA Respiratory Drug Delivery Market Attractiveness Index
16.3 MEA Respiratory Drug Delivery Market by Country, 2024, 2029 & 2034 (US$ Billion)
16.4 MEA Respiratory Drug Delivery Market Size Estimation and Forecast by Country
16.5 MEA Respiratory Drug Delivery Market Size Estimation and Forecast by Product
16.6 MEA Respiratory Drug Delivery Market Size Estimation and Forecast by Formulation
16.7 MEA Respiratory Drug Delivery Market Size Estimation and Forecast by Devices
16.8 MEA Respiratory Drug Delivery Market Size Estimation and Forecast by Application
16.9 MEA Respiratory Drug Delivery Market Size Estimation and Forecast by Canister
16.10 MEA Respiratory Drug Delivery Market Size Estimation and Forecast by Nebulizers
16.11 MEA Respiratory Drug Delivery Market Size Estimation and Forecast by End-users
16.12 GCC Respiratory Drug Delivery Market Analysis
16.13 South Africa Respiratory Drug Delivery Market Analysis
16.14 Egypt Respiratory Drug Delivery Market Analysis
16.15 Rest of MEA Respiratory Drug Delivery Market Analysis

17 Company Profiles
17.1 Competitive Landscape, 2022
17.2 GSK plc
17.2.1 Company Snapshot
17.2.2 Company Overview
17.2.3 Financial Analysis
17.2.3.1 Net Revenue, 2018-2022
17.2.3.2 R&D, 2018-2022
17.2.3.3 Regional Market Shares, 2022
17.2.4 Product Benchmarking
17.2.5 Strategic Outlook
17.3 Koninklijke Philips N.V.
17.3.1 Company Snapshot
17.3.2 Company Overview
17.3.3 Financial Analysis
17.3.3.1 Net Revenue, 2018-2022
17.3.3.2 R&D, 2018-2022
17.3.3.3 Segment Market Shares, 2022
17.3.3.4 Regional Market Shares, 2022
17.3.4 Product Benchmarking
17.3.5 Strategic Outlook
17.4 3M
17.4.1 Company Snapshot
17.4.2 Company Overview
17.4.3 Financial Analysis
17.4.3.1 Net Revenue, 2018-2022
17.4.3.2 R&D, 2018-2022
17.4.3.3 Segment Market Shares, 2022
17.4.3.4 Regional Market Shares, 2022
17.4.4 Product Benchmarking
17.4.5 Strategic Outlook
17.5 Boehringer Ingelheim International GmbH
17.5.1 Company Snapshot
17.5.2 Company Overview
17.5.3 Financial Analysis
17.5.3.1 Net Revenue, 2018-2022
17.5.3.2 Segment Market Shares, 2022
17.5.3.3 Regional Market Shares, 2022
17.5.4 Product Benchmarking
17.5.5 Strategic Outlook
17.6 AstraZeneca
17.6.1 Company Snapshot
17.6.2 Company Overview
17.6.3 Financial Analysis
17.6.3.1 Net Revenue, 2018-2022
17.6.3.2 R&D, 2018-2022
17.6.3.3 Segment Market Shares, 2022
17.6.3.4 Regional Market Shares, 2022
17.6.4 Product Benchmarking
17.6.5 Strategic Outlook
17.7 Merck & Co., Inc.
17.7.1 Company Snapshot
17.7.2 Company Overview
17.7.3 Financial Analysis
17.7.3.1 Net Revenue, 2018-2022
17.7.3.2 R&D, 2018-2022
17.7.3.3 Segment Market Shares, 2022
17.7.3.4 Regional Market Shares, 2022
17.7.4 Product Benchmarking
17.7.5 Strategic Outlook
17.8 Novartis AG
17.8.1 Company Snapshot
17.8.2 Company Overview
17.8.3 Financial Analysis
17.8.3.1 Net Revenue, 2018-2022
17.8.3.2 R&D, 2018-2022
17.8.3.3 Segment Market Shares, 2022
17.8.3.4 Regional Market Shares, 2022
17.8.4 Product Benchmarking
17.8.5 Strategic Outlook
17.9 Omron Corporation
17.9.1 Company Snapshot
17.9.2 Company Overview
17.9.3 Financial Analysis
17.9.3.1 Net Revenue, 2018-2022
17.9.3.2 R&D, 2018-2022
17.9.3.3 Segment Market Shares, 2022
17.9.3.4 Regional Market Shares, 2022
17.9.4 Product Benchmarking
17.9.5 Strategic Outlook
17.10 Sumitomo Pharma Co., Ltd.
17.10.1 Company Snapshot
17.10.2 Company Overview
17.10.3 Financial Analysis
17.10.3.1 Net Revenue, 2019-2023
17.10.3.2 R&D, 2019-2023
17.10.4 Product Benchmarking
17.10.5 Strategic Outlook
17.11 Teva Pharmaceutical Industries Ltd.
17.11.1 Company Snapshot
17.11.2 Company Overview
17.11.3 Financial Analysis
17.11.3.1 Net Revenue, 2018-2022
17.11.3.2 R&D, 2018-2022
17.11.3.3 Regional Market Shares, 2022
17.11.4 Product Benchmarking
17.11.5 Strategic Outlook
17.12 Cipla Inc.
17.12.1 Company Snapshot
17.12.2 Company Overview
17.12.3 Financial Analysis
17.12.3.1 Net Revenue, 2019-2023
17.12.3.2 Segment Market Shares, 2023
17.12.3.3 Regional Market Shares, 2023
17.12.4 Product Benchmarking
17.12.5 Strategic Outlook
17.13 Medisana GmbH
17.13.1 Company Snapshot
17.13.2 Company Overview
17.13.3 Product Benchmarking
17.14 GF Health Products, Inc.
17.14.1 Company Snapshot
17.14.2 Company Overview
17.14.3 Product Benchmarking
17.15 AptarGroup, Inc.
17.15.1 Company Snapshot
17.15.2 Company Overview
17.15.3 Financial Analysis
17.15.3.1 Net Revenue, 2018-2022
17.15.3.2 R&D, 2018-2022
17.15.3.3 Segment Market Shares, 2022
17.15.3.4 Regional Market Shares, 2022
17.15.4 Product Benchmarking
17.15.5 Strategic Outlook
17.16 Recipharm AB
17.16.1 Company Snapshot
17.16.2 Company Overview
17.16.3 Financial Analysis
17.16.3.1 Net Revenue, 2018-2022
17.16.4 Product Benchmarking
17.16.5 Strategic Outlook
17.17 Glenmark Pharmaceuticals Ltd.
17.17.1 Company Snapshot
17.17.2 Company Overview
17.17.3 Financial Analysis
17.17.3.1 Net Revenue, 2018-2022
17.17.3.2 Regional Market Shares, 2022
17.17.4 Product Benchmarking
17.18 Vapotherm, Inc.
17.18.1 Company Snapshot
17.18.2 Company Overview
17.18.3 Financial Analysis
17.18.3.1 Net Revenue, 2018-2022
17.18.3.2 R&D, 2018-2022
17.18.3.3 Segment Market Shares, 2022
17.18.3.4 Regional Market Shares, 2022
17.18.4 Product Benchmarking
17.18.5 Strategic Outlook

18 Conclusion and Recommendations
18.1 Concluding Remarks from Visiongain
18.2 Recommendations for Market Players

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1 Respiratory Drug Delivery Market Snapshot, 2024 & 2034 (US$ Billion, CAGR %)
Table 2 Respiratory Drug Delivery Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “V” Shaped Recovery
Table 3 Respiratory Drug Delivery Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “U” Shaped Recovery
Table 4 Respiratory Drug Delivery Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “W” Shaped Recovery
Table 5 Respiratory Drug Delivery Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “L” Shaped Recovery
Table 6 Respiratory Drug Delivery Market Forecast by Product, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 7 Formulations Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 8 Devices Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 9 Respiratory Drug Delivery Market by Formulations, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 10 Dry Powder Formulation Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 11 Suspension aerosol Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 12 Solution Aerosol Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 13 Respiratory Drug Delivery Market Forecast by Devices, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 14 Metered Dose Inhaler (MDIs) Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 15 Dry Powder Inhalers (DPIs) Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 16 Nebulizers Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 17 Accessories Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 18 Respiratory Drug Delivery Market by Nebulizers, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 19 Soft Mist Nebulizers Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 20 Jet Nebulizers Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 21 Ultrasonic Nebulizers Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 22 Respiratory Drug Delivery Market Forecast by Canister, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 23 Plain canisters Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 24 Coated canisters Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 25 Respiratory Drug Delivery Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 26 Asthma Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 27 Chronic Obstructive Pulmonary Disease (COPD) Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 28 Cystic Fibrosis Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 29 Others Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 30 Respiratory Drug Delivery Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 31 Homecare Settings Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 32 Hospital & Clinics Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 33 Other End-users Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 34 Respiratory Drug Delivery Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 35 North America Respiratory Drug Delivery Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 36 North America Respiratory Drug Delivery Market Forecast by Product, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 37 North America Respiratory Drug Delivery Market Forecast by Formulation, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 38 North America Respiratory Drug Delivery Market Forecast by Devices, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 39 North America Respiratory Drug Delivery Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 40 North America Respiratory Drug Delivery Market Forecast by Canister, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 41 North America Respiratory Drug Delivery Market Forecast by Nebulizers, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 42 North America Respiratory Drug Delivery Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 43 U.S. Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 44 Canada Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 45 Europe Respiratory Drug Delivery Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 46 Europe Respiratory Drug Delivery Market Forecast by Product, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 47 Europe Respiratory Drug Delivery Market Forecast by Formulation, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 48 Europe Respiratory Drug Delivery Market Forecast by Devices, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 49 Europe Respiratory Drug Delivery Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 50 Europe Respiratory Drug Delivery Market Forecast by Canister, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 51 Europe Respiratory Drug Delivery Market Forecast by Nebulizers, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 52 Europe Respiratory Drug Delivery Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 53 Germany Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 54 UK Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 55 France Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 56 Italy Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 57 Spain Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 58 Switzerland Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 59 Russia Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 60 Rest of Europe Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 61 Asia Pacific Respiratory Drug Delivery Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 62 Asia Pacific Respiratory Drug Delivery Market Forecast by Product, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 63 Asia Pacific Respiratory Drug Delivery Market Forecast by Formulation, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 64 Asia Pacific Respiratory Drug Delivery Market Forecast by Devices, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 65 Asia Pacific Respiratory Drug Delivery Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 66 Asia Pacific Respiratory Drug Delivery Market Forecast by Canister, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 67 Asia Pacific Respiratory Drug Delivery Market Forecast by Nebulizers, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 68 Asia Pacific Respiratory Drug Delivery Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 69 Japan Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 70 China Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 71 India Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 72 Australia Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 73 South Korea Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 74 South East Asia Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 75 Rest of Asia Pacific Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 76 Latin America Respiratory Drug Delivery Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 77 Latin America Respiratory Drug Delivery Market Forecast by Product, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 78 Latin America Respiratory Drug Delivery Market Forecast by Formulation, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 79 Latin America Respiratory Drug Delivery Market Forecast by Devices, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 80 Latin America Respiratory Drug Delivery Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 81 Latin America Respiratory Drug Delivery Market Forecast by Canister, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 82 Latin America Respiratory Drug Delivery Market Forecast by Nebulizers, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 83 Latin America Respiratory Drug Delivery Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 84 Brazil Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 85 Mexico Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 86 Argentina Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 87 Rest of Latin America Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 88 MEA Respiratory Drug Delivery Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 89 MEA Respiratory Drug Delivery Market Forecast by Product, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 90 MEA Respiratory Drug Delivery Market Forecast by Formulation, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 91 MEA Respiratory Drug Delivery Market Forecast by Devices, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 92 MEA Respiratory Drug Delivery Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 93 MEA Respiratory Drug Delivery Market Forecast by Canister, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 94 MEA Respiratory Drug Delivery Market Forecast by Nebulizers, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 95 MEA Respiratory Drug Delivery Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 96 GCC Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 97 South Africa Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 98 Egypt Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 99 Rest of MEA Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 100 GSK plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 GSK plc: Product Benchmarking
Table 102 GSK plc: Strategic Outlook
Table 103 Koninklijke Philips N.V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Koninklijke Philips N.V.: Product Benchmarking
Table 105 Koninklijke Philips N.V.: Strategic Outlook
Table 106 3M: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 3M: Product Benchmarking
Table 108 3M: Strategic Outlook
Table 109 Boehringer Ingelheim International GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 Boehringer Ingelheim International GmbH: Product Benchmarking
Table 111 Boehringer Ingelheim International GmbH: Strategic Outlook
Table 112 AstraZeneca: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 113 AstraZeneca: Product Benchmarking
Table 114 AstraZeneca: Strategic Outlook
Table 115 Merck & Co., Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 116 Merck & Co., Inc.: Product Benchmarking
Table 117 Merck & Co., Inc.: Strategic Outlook
Table 118 Novartis AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 119 Novartis AG: Product Benchmarking
Table 120 Novartis AG: Strategic Outlook
Table 121 Omron Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 122 Omron Corporation.: Product Benchmarking
Table 123 Omron Corporation.: Strategic Outlook
Table 124 Sumitomo Pharma Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 125 Sumitomo Pharma Co., Ltd.: Product Benchmarking
Table 126 Sumitomo Pharma Co., Ltd.: Strategic Outlook
Table 127 Teva Pharmaceutical Industries Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 128 Teva Pharmaceutical Industries Ltd.: Product Benchmarking
Table 129 Teva Pharmaceutical Industries Ltd.: Strategic Outlook
Table 130 Cipla Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 131 Cipla Inc.: Product Benchmarking
Table 132 Cipla Inc.: Strategic Outlook
Table 133 Medisana GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 134 Medisana GmbH: Product Benchmarking
Table 135 GF Health Products, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 136 GF Health Products, Inc.: Product Benchmarking
Table 137 AptarGroup, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 138 AptarGroup, Inc.: Product Benchmarking
Table 139 AptarGroup, Inc.: Strategic Outlook
Table 140 Recipharm AB: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 141 Recipharm AB: Product Benchmarking
Table 142 Recipharm AB: Strategic Outlook
Table 143 Glenmark Pharmaceuticals Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 144 Glenmark Pharmaceuticals Ltd.: Product Benchmarking
Table 145 Vapotherm, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 146 Vapotherm, Inc.: Product Benchmarking
Table 147 Vapotherm, Inc.: Strategic Outlook

List of Figures
Figure 1 Respiratory Drug Delivery Market Segmentation
Figure 2 Respiratory Drug Delivery Market Attractiveness Index by Region
Figure 3 Respiratory Drug Delivery Market by Product: Market Attractiveness Index
Figure 4 Respiratory Drug Delivery Market by Formulation: Market Attractiveness Index
Figure 5 Respiratory Drug Delivery Market by Devices: Market Attractiveness Index
Figure 6 Respiratory Drug Delivery Market by Application: Market Attractiveness Index
Figure 7 Respiratory Drug Delivery Market by Canister: Market Attractiveness Index
Figure 8 Respiratory Drug Delivery Market by Nebulizers: Market Attractiveness Index
Figure 9 Respiratory Drug Delivery Market by End-users: Market Attractiveness Index
Figure 10 Respiratory Drug Delivery Market: Market Dynamics
Figure 11 Hospital Discharge Rates for In-patients with Disease of Respiratory Systems, Per 100,000 Inhabitants by Country, 2021
Figure 12 Respiratory Drug Delivery Market by Region, 2024-2034 (US$ Billion, AGR %): “V” Shaped Recovery
Figure 13 Respiratory Drug Delivery Market by Region, 2024-2034 (US$ Billion, AGR %): “U” Shaped Recovery
Figure 14 Respiratory Drug Delivery Market by Region, 2024-2034 (US$ Billion, AGR %): “W” Shaped Recovery
Figure 15 Respiratory Drug Delivery Market by Region, 2024-2034 (US$ Billion, AGR %): “L” Shaped Recovery
Figure 16 Respiratory Drug Delivery Market: Porter’s Five Forces Analysis
Figure 17 Respiratory Drug Delivery Market: SWOT Analysis
Figure 18 Respiratory Drug Delivery Market: PEST Analysis
Figure 19 Respiratory Drug Delivery Market by Product: Market Attractiveness Index
Figure 20 Respiratory Drug Delivery Market Forecast by Product, 2024-2034 (US$ Billion, AGR %)
Figure 21 Respiratory Drug Delivery Market Share Forecast by Product, 2024, 2029, 2034 (%)
Figure 22 Formulations Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 23 Formulations Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 24 Devices Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 25 Devices Market Share Forecast by Region, 2024 & 2034 (%)
Figure 26 Respiratory Drug Delivery Market by Formulations: Market Attractiveness Index
Figure 27 Respiratory Drug Delivery Market by Type, 2024-2034 (US$ Billion)
Figure 28 Respiratory Drug Delivery Market Share Forecast by Formulations,2024, 2029, 2034 (%)
Figure 29 Dry Powder Formulation Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 30 Dry Powder Formulation Market Share Forecast by Region, 2024 & 2034 (%)
Figure 31 Suspension aerosol Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 32 Suspension aerosol Market Share Forecast by Region, 2024 & 2034 (%)
Figure 33 Solution Aerosol Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 34 Solution Aerosol Market Share Forecast by Region, 2024 & 2034 (%)
Figure 35 Respiratory Drug Delivery Market by Devices: Market Attractiveness Index
Figure 36 Respiratory Drug Delivery Market Forecast by Type, 2024-2034 (US$ Billion)
Figure 37 Respiratory Drug Delivery Market Share Forecast by Type, 2024, 2029, 2034 (%)
Figure 38 Metered Dose Inhaler (MDIs) Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 39 Metered Dose Inhaler (MDIs) Market Share Forecast by Region, 2024 & 2034 (%)
Figure 40 Dry Powder Inhalers (DPIs) Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 41 Dry Powder Inhalers (DPIs) Market Share Forecast by Region, 2024 & 2034 (%)
Figure 42 Nebulizers Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 43 Nebulizers Market Share Forecast by Region, 2024 & 2034 (%)
Figure 44 Accessories Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 45 Accessories Market Share Forecast by Region, 2024 & 2034 (%)
Figure 46 Respiratory Drug Delivery Market by Nebulizers: Market Attractiveness Index
Figure 47 Respiratory Drug Delivery Market by Nebulizers, 2024-2034 (US$ Billion)
Figure 48 Respiratory Drug Delivery Market Share by Nebulizers, 2024, 2029, 2034 (%)
Figure 49 Soft Mist Nebulizers Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 50 Soft Mist Nebulizers Market Share Forecast by Region, 2024 & 2034 (%)
Figure 51 Jet Nebulizers Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 52 Jet Nebulizers Market Share Forecast by Region, 2024 & 2034 (%)
Figure 53 Ultrasonic Nebulizers Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 54 Ultrasonic Nebulizers Market Share Forecast by Region, 2024 & 2034 (%)
Figure 55 Respiratory Drug Delivery Market by Canister: Market Attractiveness Index
Figure 56 Respiratory Drug Delivery Market Forecast by Canister, 2024-2034 (US$ Billion)
Figure 57 Respiratory Drug Delivery Market Share Forecast by Canister, 2024, 2029, 2034 (%)
Figure 58 Plain canisters Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 59 Plain canisters Market Share Forecast by Region, 2024 & 2034 (%)
Figure 60 Coated canisters Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 61 Coated canisters Market Share Forecast by Region, 2024 & 2034 (%)
Figure 62 Respiratory Drug Delivery Market by Application: Market Attractiveness Index
Figure 63 Respiratory Drug Delivery Market Forecast by Application, 2024-2034 (US$ Billion)
Figure 64 Respiratory Drug Delivery Market Share Forecast by Application, 2024, 2029, 2034 (%)
Figure 65 Asthma Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 66 Asthma Market Share Forecast by Region, 2024 & 2034 (%)
Figure 67 Chronic Obstructive Pulmonary Disease (COPD) Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 68 Chronic Obstructive Pulmonary Disease (COPD) Market Share Forecast by Region, 2024 & 2034 (%)
Figure 69 Cystic Fibrosis Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 70 Cystic Fibrosis Market Share Forecast by Region, 2024 & 2034 (%)
Figure 71 Others Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 72 Others Market Share Forecast by Region, 2024 & 2034 (%)
Figure 73 Respiratory Drug Delivery Market by End-users: Market Attractiveness Index
Figure 74 Respiratory Drug Delivery Market Forecast by End-users, 2024-2034 (US$ Billion)
Figure 75 Respiratory Drug Delivery Market Share Forecast by End-users, 2024, 2029, 2034 (%)
Figure 76 Homecare Settings Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 77 Homecare Settings Market Share Forecast by Region, 2024 & 2034 (%)
Figure 78 Hospital & Clinics Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 79 Hospital & Clinics Market Share Forecast by Region, 2024 & 2034 (%)
Figure 80 Other End-users Market Forecast by Region, 2024-2034 (US$ Billion)
Figure 81 Others Market Share Forecast by Region, 2024 & 2034 (%)
Figure 82 Respiratory Drug Delivery Market Forecast by Region 2024 and 2034 (Revenue, CAGR%)
Figure 83 Respiratory Drug Delivery Market Share Forecast by Region 2024, 2029, 2034 (%)
Figure 84 Respiratory Drug Delivery Market by Region, 2024-2034 (US$ Billion, AGR %)
Figure 85 North America Respiratory Drug Delivery Market Attractiveness Index
Figure 86 North America Respiratory Drug Delivery Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 87 North America Respiratory Drug Delivery Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 88 North America Respiratory Drug Delivery Market Share Forecast by Country, 2024 & 2034 (%)
Figure 89 North America Respiratory Drug Delivery Market Forecast by Product, 2024-2034 (US$ Billion, AGR %)
Figure 90 North America Respiratory Drug Delivery Market Share Forecast by Product, 2024 & 2034 (%)
Figure 91 North America Respiratory Drug Delivery Market Forecast by Formulation, 2024-2034 (US$ Billion, AGR %)
Figure 92 North America Respiratory Drug Delivery Market Share Forecast by Formulation, 2024 & 2034 (%)
Figure 93 North America Respiratory Drug Delivery Market Forecast by Devices, 2024-2034 (US$ Billion, AGR %)
Figure 94 North America Respiratory Drug Delivery Market Share Forecast by Devices, 2024 & 2034 (%)
Figure 95 North America Respiratory Drug Delivery Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 96 North America Respiratory Drug Delivery Market Share Forecast by Application, 2024 & 2034 (%)
Figure 97 North America Respiratory Drug Delivery Market Forecast by Canister, 2024-2034 (US$ Billion, AGR %)
Figure 98 North America Respiratory Drug Delivery Market Share Forecast by Canister, 2024 & 2034 (%)
Figure 99 North America Respiratory Drug Delivery Market Forecast by Nebulizers, 2024-2034 (US$ Billion, AGR %)
Figure 100 North America Respiratory Drug Delivery Market Share Forecast by Nebulizers, 2024 & 2034 (%)
Figure 101 North America Respiratory Drug Delivery Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
Figure 102 North America Respiratory Drug Delivery Market Share Forecast by End-users, 2024 & 2034 (%)
Figure 103 U.S. Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 104 Canada Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 105 Europe Respiratory Drug Delivery Market Attractiveness Index
Figure 106 Europe Respiratory Drug Delivery Market by Country, 2024, 2029 & 2034 (US$ Billion)
Figure 107 Europe Respiratory Drug Delivery Market Forecast by Country, 2024-2034 (US$ Billion)
Figure 108 Europe Respiratory Drug Delivery Market Share Forecast by Country, 2024 & 2034 (%)
Figure 109 Europe Respiratory Drug Delivery Market Forecast by Product, 2024-2034 (US$ Billion)
Figure 110 Europe Respiratory Drug Delivery Market Share Forecast by Product, 2024 & 2034 (%)
Figure 111 Europe Respiratory Drug Delivery Market Forecast by Formulation, 2024-2034 (US$ Billion)
Figure 112 Europe Respiratory Drug Delivery Market Share Forecast by Formulation, 2024 & 2034 (%)
Figure 113 Europe Respiratory Drug Delivery Market Forecast by Devices, 2024-2034 (US$ Billion)
Figure 114 Europe Respiratory Drug Delivery Market Share Forecast by Devices, 2024 & 2034 (%)
Figure 115 Europe Respiratory Drug Delivery Market Forecast by Application, 2024-2034 (US$ Billion)
Figure 116 Europe Respiratory Drug Delivery Market Share Forecast by Application, 2024 & 2034(%)
Figure 117 Europe Respiratory Drug Delivery Market Forecast by Canister, 2024-2034 (US$ Billion)
Figure 118 Europe Respiratory Drug Delivery Market Share Forecast by Canister, 2024 & 2034(%)
Figure 119 Europe Respiratory Drug Delivery Market Forecast by Nebulizers, 2024-2034 (US$ Billion)
Figure 120 Europe Respiratory Drug Delivery Market Share Forecast by Nebulizers, 2024 & 2034(%)
Figure 121 Europe Respiratory Drug Delivery Market Forecast by End-users, 2024-2034 (US$ Billion)
Figure 122 Europe Respiratory Drug Delivery Market Share Forecast by End-users, 2024 & 2034(%)
Figure 123 Germany Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 124 UK Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 125 France Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 126 Italy Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 127 Spain Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 128 Switzerland Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 129 Russia Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 130 Rest of Europe Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 131 Asia Pacific Respiratory Drug Delivery Market Attractiveness Index
Figure 132 Asia Pacific Respiratory Drug Delivery Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 133 Asia Pacific Respiratory Drug Delivery Market Forecast by Country, 2024-2034 (US$ Billion)
Figure 134 Asia Pacific Respiratory Drug Delivery Market Share Forecast by Country, 2024 & 2034 (%)
Figure 135 Asia Pacific Respiratory Drug Delivery Market Forecast by Product, 2024-2034 (US$ Billion)
Figure 136 Asia Pacific Respiratory Drug Delivery Market Share Forecast by Product, 2024 & 2034 (%)
Figure 137 Asia Pacific Respiratory Drug Delivery Market Forecast by Formulation, 2024-2034 (US$ Billion)
Figure 138 Asia Pacific Respiratory Drug Delivery Market Share Forecast by Formulation, 2024 & 2034 (%)
Figure 139 Asia Pacific Respiratory Drug Delivery Market Forecast by Devices, 2024-2034 (US$ Billion)
Figure 140 Asia Pacific Respiratory Drug Delivery Market Share Forecast by Devices, 2024 & 2034 (%)
Figure 141 Asia Pacific Respiratory Drug Delivery Market Forecast by Application, 2024-2034 (US$ Billion)
Figure 142 Asia Pacific Respiratory Drug Delivery Market Share Forecast by Application, 2024 & 2034 (%)
Figure 143 Asia Pacific Respiratory Drug Delivery Market Forecast by Canister, 2024-2034 (US$ Billion)
Figure 144 Asia Pacific Respiratory Drug Delivery Market Share Forecast by Canister, 2024 & 2034 (%)
Figure 145 Asia Pacific Respiratory Drug Delivery Market Forecast by Nebulizers, 2024-2034 (US$ Billion)
Figure 146 Asia Pacific Respiratory Drug Delivery Market Share Forecast by Nebulizers, 2024 & 2034 (%)
Figure 147 Asia Pacific Respiratory Drug Delivery Market Forecast by End-users, 2024-2034 (US$ Billion)
Figure 148 Asia Pacific Respiratory Drug Delivery Market Share Forecast by End-users, 2024 & 2034 (%)
Figure 149 Japan Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 150 China Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 151 India Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 152 Australia Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 153 South Korea Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 154 South East Asia Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 155 Rest of Asia Pacific Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 156 Latin America Respiratory Drug Delivery Market Attractiveness Index
Figure 157 Latin America Respiratory Drug Delivery Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 158 Latin America Respiratory Drug Delivery Market Forecast by Country, 2024-2034 (US$ Billion)
Figure 159 Latin America Respiratory Drug Delivery Market Share Forecast by Country, 2024 & 2034 (%)
Figure 160 Latin America Respiratory Drug Delivery Market Forecast by Product, 2024-2034 (US$ Billion)
Figure 161 Latin America Respiratory Drug Delivery Market Share Forecast by Product, 2024 & 2034 (%)
Figure 162 Latin America Respiratory Drug Delivery Market Forecast by Formulation, 2024-2034 (US$ Billion)
Figure 163 Latin America Respiratory Drug Delivery Market Share Forecast by Formulation, 2024 & 2034 (%)
Figure 164 Latin America Respiratory Drug Delivery Market Forecast by Devices, 2024-2034 (US$ Billion)
Figure 165 Latin America Respiratory Drug Delivery Market Share Forecast by Devices, 2024 & 2034 (%)
Figure 166 Latin America Respiratory Drug Delivery Market Forecast by Application, 2024-2034 (US$ Billion)
Figure 167 Latin America Respiratory Drug Delivery Market Share Forecast by Application, 2024 & 2034 (%)
Figure 168 Latin America Respiratory Drug Delivery Market Forecast by Canister, 2024-2034 (US$ Billion)
Figure 169 Latin America Respiratory Drug Delivery Market Share Forecast by Canister, 2024 & 2034 (%)
Figure 170 Latin America Respiratory Drug Delivery Market Forecast by Nebulizers, 2024-2034 (US$ Billion)
Figure 171 Latin America Respiratory Drug Delivery Market Share Forecast by Nebulizers, 2024 & 2034 (%)
Figure 172 Latin America Respiratory Drug Delivery Market Forecast by End-users, 2024-2034 (US$ Billion)
Figure 173 Latin America Respiratory Drug Delivery Market Share Forecast by End-users, 2024 & 2034 (%)
Figure 174 Brazil Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 175 Mexico Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 176 Argentina Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 177 Rest of Latin America Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 178 MEA Respiratory Drug Delivery Market Attractiveness Index
Figure 179 MEA Respiratory Drug Delivery Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 180 MEA Respiratory Drug Delivery Market Forecast by Country, 2024-2034 (US$ Billion)
Figure 181 MEA Respiratory Drug Delivery Market Share Forecast by Country, 2024 & 2034 (%)
Figure 182 MEA Respiratory Drug Delivery Market Forecast by Product, 2024-2034 (US$ Billion)
Figure 183 MEA Respiratory Drug Delivery Market Share Forecast by Product, 2024 & 2034 (%)
Figure 184 MEA Respiratory Drug Delivery Market Forecast by Formulation, 2024-2034 (US$ Billion)
Figure 185 MEA Respiratory Drug Delivery Market Share Forecast by Formulation, 2024 & 2034 (%)
Figure 186 MEA Respiratory Drug Delivery Market Forecast by Devices, 2024-2034 (US$ Billion)
Figure 187 MEA Respiratory Drug Delivery Market Share Forecast by Devices, 2024 & 2034 (%)
Figure 188 MEA Respiratory Drug Delivery Market Forecast by Application, 2024-2034 (US$ Billion)
Figure 189 MEA Respiratory Drug Delivery Market Share Forecast by Application, 2024 & 2034 (%)
Figure 190 MEA Respiratory Drug Delivery Market Forecast by Canister, 2024-2034 (US$ Billion)
Figure 191 MEA Respiratory Drug Delivery Market Share Forecast by Canister, 2024 & 2034 (%)
Figure 192 MEA Respiratory Drug Delivery Market Forecast by Nebulizers, 2024-2034 (US$ Billion)
Figure 193 MEA Respiratory Drug Delivery Market Share Forecast by Nebulizers, 2024 & 2034 (%)
Figure 194 MEA Respiratory Drug Delivery Market Forecast by End-users, 2024-2034 (US$ Billion)
Figure 195 MEA Respiratory Drug Delivery Market Share Forecast by End-users, 2024 & 2034 (%)
Figure 196 GCC Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 197 South Africa Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 198 Egypt Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 199 Rest of MEA Respiratory Drug Delivery Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 200 Respiratory Drug Delivery Market: Company Share/Ranking, 2022
Figure 201 GSK plc: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 202 GSK plc: R&D, 2018-2022 (US$ Million, AGR %)
Figure 203 GSK plc: Regional Market Shares, 2022
Figure 204 Koninklijke Philips N.V.: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 205 Koninklijke Philips N.V.: R&D, 2018-2022 (US$ Million, AGR %)
Figure 206 Koninklijke Philips N.V.: Segment Market Shares, 2022
Figure 207 Koninklijke Philips N.V.: Regional Market Shares, 2022
Figure 208 3M: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 209 3M: R&D, 2018-2022 (US$ Million, AGR %)
Figure 210 3M: Segment Market Shares, 2022
Figure 211 3M: Regional Market Shares, 2022
Figure 212 Boehringer Ingelheim International GmbH: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 213 Boehringer Ingelheim International GmbH: Segment Market Shares, 2022
Figure 214 Boehringer Ingelheim International GmbH: Regional Market Shares, 2022
Figure 215 AstraZeneca: Net Revenue, 2018-2022 (US$ Million, AGR (%)
Figure 216 AstraZeneca: R&D, 2018-2022 (US$ Million, AGR %)
Figure 217 AstraZeneca: Segment Market Shares, 2022
Figure 218 AstraZeneca: Regional Market Shares, 2022
Figure 219 Merck & Co., Inc.: Net Revenue, 2018-2022 (US$ Million, AGR (%)
Figure 220 Merck & Co., Inc.: R&D, 2018-2022 (US$ Million, AGR %)
Figure 221 Merck & Co., Inc.: Segment Market Shares, 2022
Figure 222 Merck & Co., Inc.: Regional Market Shares, 2022
Figure 223 Novartis AG: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 224 Novartis AG: R&D, 2018-2022 (US$ Million, AGR %)
Figure 225 Novartis AG: Segment Market Shares, 2022
Figure 226 Novartis AG: Regional Market Shares, 2022
Figure 227 Omron Corporation: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 228 Omron Corporation: R&D, 2018-2022 (US$ Million, AGR %)
Figure 229 Omron Corporation: Segment Market Shares, 2022
Figure 230 Omron Corporation: Regional Market Shares, 2022
Figure 231 Sumitomo Pharma Co., Ltd.: Net Revenue, 2019-2023 (US$ Million, AGR %)
Figure 232 Sumitomo Pharma Co., Ltd.: R&D, 2019-2023 (US$ Million, AGR %)
Figure 233 Teva Pharmaceutical Industries Ltd.: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 234 Teva Pharmaceutical Industries Ltd.: R&D, 2018-2022 (US$ Million, AGR %)
Figure 235 Teva Pharmaceutical Industries Ltd.: Regional Market Shares, 2022
Figure 236 Cipla Inc.: Net Revenue, 2019-2023 (US$ Million, AGR %)
Figure 237 Cipla Inc.: Segment Market Shares, 2023
Figure 238 Cipla Inc.: Regional Market Shares, 2023
Figure 239 AptarGroup, Inc.: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 240 AptarGroup, Inc.: R&D, 2018-2022 (US$ Million, AGR %)
Figure 241 AptarGroup, Inc.: Segment Market Shares, 2022
Figure 242 AptarGroup, Inc.: Regional Market Shares, 2022
Figure 243 Recipharm AB: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 244 Glenmark Pharmaceuticals Ltd.: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 245 Glenmark Pharmaceuticals Ltd.: Regional Market Shares, 2022
Figure 246 Vapotherm, Inc.: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 247 Vapotherm, Inc.: R&D, 2018-2022 (US$ Million, AGR %)
Figure 248 Vapotherm, Inc.: Segment Market Shares, 2022
Figure 249 Vapotherm, Inc.: Regional Market Shares, 2022

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（個々の器官作用薬）の最新刊レポート

Visiongain社の医薬・化学品分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

Visiongain社はどのような調査会社ですか?

英国の調査会社ヴィジョンゲイン社（Visiongain）は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

呼吸器薬物送達市場レポート：2024-2034

サマリー

目次

図表リスト

Summary

Table of Contents

List of Tables/Graphs

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（個々の器官作用薬）の最新刊レポート

Visiongain社の医薬・化学品分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

よくあるご質問

Visiongain社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?